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ABSTRACT
Vasquez Mejia, Clara M. M.S., Purdue University, May 2014. Effect of carvacrol-loaded
nanoemulsions on a bioluminescent strain of Escherichia coli O157:H7. Major Professors:
Maria Fernanda San Martin-Gonzalez and Bruce M. Applegate.

Nanoemulsions have been shown to be effective delivery vehicles for natural
antimicrobials that are poorly soluble in water. In this study the antimicrobial activity of
carvacrol (5-isopropyl-2-methylphenol) nanoemulsions against a bioluminescent
Escherichia coli O157:H7 was investigated using light emission as an indicator of cell
viability. Different emulsifiers (Ultralec Lecithin and Tween 20), oils (Palm stearin and
Coconut oil) and various carvacrol concentrations (0, 1, 2 and 2.5%) were evaluated.
Bioluminescence was monitored in situ using a Hamamatsu (photo multiplier tube)
sensor module integrated with a Programmable Logic Controller interfaced with a PC for
data acquisition. Bioluminescence decreased rapidly with the addition of emulsions
containing increasing concentrations of carvacrol (250ppm-1000ppm). However when
cells were assayed for viability, plate counts showed there was not a correlation of
bioluminescence to cell inactivation. Bioluminescence was able to recover after the
removal of carvacrol from the surrounding media. The same bioluminescent pattern was
also observed with sub-lethal doses of the oxidative uncoupler 2,4-dinitrophenol and the
supplementary addition of the luciferase reaction substrate recovered the light emission in
presence of carvacrol.

xiii
These results suggest that carvacrol and 2,4-DNP uncouple oxidative
phosphorylation reducing the ATP available for the biosynthesis of the aldehyde
substrate. Previous reports suggested the mechanism of inactivation of carvacrol was
membrane damage resulting in loss of cellular contents and viability. However the
results of this work suggest that the mechanism of carvacrol inactivation is due to the
uncoupling of oxidative phosphorylation.
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CHAPTER 1. INTRODUCTION

The main objectives of this work are: 1) assess the in vitro and in vivo antimicrobial
efficiency of nanoemulsions containing carvacrol against a bioluminescent strain of
Escherichia coli O157:H7. 2) Investigate the antimicrobial mechanism of action of
carvacrol using the bioluminescent bioreporter Escherichia coli O157:H7 lux as a target.
The following section is divided into four main subdivisions: Escherichia coli
O157:H7, bioluminescence, nanoemulsions and natural antimicrobials. An extensive
literature review was conducted on each topic in order to build an appropriate
background and achieve the objectives of this work.
The section of Escherichia coli O157:H7 covers the taxonomy of this pathogen and
recent outbreaks on leafy greens in the United States. The second section explains in
detail bioluminescent reporters and bacterial luciferase. The third section is dedicated to
nanoemulsions and their functional properties, including their role as natural
antimicrobial vehicles. The natural antimicrobial section covers in more detail their
properties and specifically, is focused on the antimicrobial effect of carvacrol.
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CHAPTER 2. LITERATURE REVIEW

2.1

Escherichia coli O157:H7

Nonpathogenic Escherichia coli is naturally found in the gastrointestinal flora.
However, some Escherichia coli strains can cause gastrointestinal, urinary or central
nervous system diseases during infection. Escherichia coli are serotyped based on their
surface antigen profile: Somatic (O), flagellar (H) and capsular (H) (Nataro and Kaper
1998). In 1982, Escherichia coli O157:H7 was first recognized as a pathogen, after being
found in 58% of patients with Hemolytic Uremic Syndrome (HUS) (Neill et al. 1987).
HUS symptoms include decreased frequency of urination (renal insufficiency), tiredness,
and loss of pink color in cheeks and inside the lower eyelids (known as hemolytic anemia
and thrombocytopenia respectively). Strains with the ability to produce shiga toxin (Stx)
are called STEC such as Escherichia coli O157:H7 (now and on referred as E. coli
O157:H7) (Neill et al. 1987). Shiga toxin is composed by two subunits (A-B), where A
contains the enzymatically active molecule and B has the ability to bind with the
holotoxin receptor to the target eukaryotic cell (Neill et al. 1987). The eae (E. coli
attaching and effacing) gene has been found to be essential for the production of Shigatoxin, and the “attaching and effacing” (A/E) effect (Yu and Kaper 1992). The A/E effect
is the intimate attachment of the bacterial cells to the intestinal epithelial by the
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destruction of microvilli and disrupttion of the ccellular cytooskeleton (G
Griffin and T
Tauxe
1991, Yu and
d Kaper 1992
2, Chen et all. 2013).
An outb
break is deffined as an incident in w
which two or more peopple experience an
illlness resultiing from the ingestion of a comm
mon food (CDC 1997). The timelinne for
reeporting casses of E. coli O157:H7 takes from
m 6 to 23 daays and thee order of steps
fo
ollowed aree: ingestion of contaminated foodd, patient becomes ill, stool samppling,
id
dentification
n of E. colii O157:H7, verificationn by a Pubblic Health Laboratoryy and
co
onfirmation of case (Fig
gure 1) (CDC
C 2011).

Figure
F
1. Graphic repreesentation of timeline foor reportingg cases. Thee time from
where
w
the perrson gets ill to
t the confirrmation of beeing part of an outbreak takes
ap
pproximately
y 2-3 weekss. Therefore, case countss during an ooutbreak inveestigation arre
co
onsidered prreliminary an
nd must be analyzed
a
in tthe same conntext. (CDC 2011)
The CDC
C
has repo
orted several E. coli O1557:H7 outbreeaks where tthe sources oof
in
nfection are pre-packed
p
leafy
l
greens (Table 1). S
Since 1997 aall previous E
E. coli O1577:H7
ou
utbreaks were related to consumptio
on of groundd beef. Howeever in 2003, a decrease in
th
hese outbreaks was reporrted due to food
f
safety inntervention efforts with meat produccers.
The
T primary intervention
i
by the Food
d Safety andd Inspection S
Service (FSIIS) was the
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release of a notice to all raw ground beef producers to reassess their HACCP plans and no
distribution of meat should be done unless it tested negative for this pathogen (CDC 2003)
Table 1. Escherichia coli O157:H7 outbreaks. The CDC has reported four E. coli
O157:H7 outbreaks related with pre-packed leafy greens.
Year Number of cases Hospitalization Deaths HUS
Source
reported
cases
cases
199
102
3
31
Fresh Bagged
2006
Spinach
60
45
0
2
Packaged Romaine
2011
Lettuce
33
15
2
2
Pre-packed leafy
2012
greens
33
11
0
2
Ready-to-eat
2013
Salads
On 2006, a multistate (Wisconsin, Oregon and New Mexico) outbreak of E. coli
O157:H7 occurred by the consumption of bagged fresh spinach where a total of 199
people were infected, 51% were hospitalized, 15% had Hemolytic Uremic Syndrome
(HUS) and three people died (CDC 2006). The most frequently reported symptoms
among affected individuals included diarrhea (96%), abdominal cramps (96%), bloody
diarrhea (88%), fatigue (80%), watery diarrhea (63%), and chills (57%). After the
outbreak was announced by the CDC, an environmental investigation conducted jointly
by the FDA and the California Department of Health Services, Food and Drug Branch
(CDHS) reported river water, cattle feces, and wild pig feces as possible sources of the
pathogen (Wendel et al. 2009). Washing pre-packed spinach before consumption might
not decrease the risk of illness because E. coli O157:H7 could be spread from one
infected plant to the rest of the product and allow internalization in the spinach leaves
(Solomon et al. 2003).

5
Three different multistate outbreaks of E. coli O157:H7 were reported in 2011,
2012, and 2013. They were linked to romaine lettuce, pre-packaged leafy greens, and
ready-to-eat salads respectively. Unfortunately, records and traceability were not
sufficient to understand how the leafy greens growing fields became contaminated
(Slayton et al. 2013). It remains unclear if the produce was infected in the field, during
harvesting, or throughout processing as initially proposed by (Brandl 2008).
Produce contamination can occur during agricultural production (irrigation, soil,
via animals, dirty equipment, and human handling), harvesting, processing (cutting,
washing, incorrect hygiene practices, and shredding), packaging, transportation, and
distribution (Francis et al. 2012). Brandl (2008) tested the susceptibility of mechanically
damaged tissues (cut and shredded) and lesions caused by diseases (soft rot and tip burn)
to be infected by E. coli O157:H7 and concluded that this pathogen can replicate on
damaged tissues by 11-fold in just 4 h.
Therefore, the ability of E. coli O157:H7 to colonize cut tissues can be related to
its numerous outbreaks in minimally processed leafy greens and how small numbers of
pathogens can increase to minimal infection doses if post-harvest and processing is not
conducted with precaution.
Generally, bacterial identification methods include morphological evaluation of
the microorganism as well as selective enrichment exploiting the pathogens ability to
grow in several media under diverse conditions (Ivnitski et al. 1999). Traditional methods,
such as colony counting for enumerating bacteria, are often really time consuming and
non-rapid, since the development of a colony containing 106 organisms will take between
18 and 24 h (Ivnitski et al. 1999). However, over the last three decades, numerous
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im
mmunological and moleccular-based rapid assayss have been ddeveloped. E
Examples off
th
hese are: Enzzyme-linked
d immunosorrbent assay ((ELISA), DN
NA hybridizzation, and PCR
(D
Dwivedi and
d Jaykus 2011). However it is importtant to note tthat all of thhe above
teechniques arre coupled with
w a prelimiinary enrichm
ment which can last from
m 6 to 24 hoours.
Itt is clear thatt the field off food microb
bial detectioon is very dyynamic and thhe opportunnity to
develop new concepts and
d techniquess is widely oopen.

2.2

Bioluminesceent reporters

Biolum
minescence iss the producttion and emiission of lighht by a livingg organism
(H
Hastings and
d Nealson 19
977, Shimom
mura 2012). IIn biolumineescent reactiions a substrrate,
lu
uciferin, is oxidized by th
he action off the luciferasse enzyme, rresulting in eemission of a
ph
hoton (Hastiings and Neaalson 1977).. All luciferaases are oxyggenases, incoorporating
ox
xygen into th
he substrate and forming
g a moleculee (P) in an ellectronicallyy excited statte
(P
P*) with eno
ough energy to emit a ph
hoton (Hastinngs 1983). T
The general bbioluminesceent
reeaction can be
b summarizzed as:

E
Equation 1
Biorep
porters are liiving microo
organisms thhat are susceeptible to chaanges in the
en
nvironment by displayin
ng a specific and easily m
measurable ssignal (Van D
Der Meer et al.
2004) whereaas the signal produced is proportionaal to the anallyte concentrration (Lei eet al.
microorganism
ms
2006). An oftten used biorreporter are bioluminesccence-based,, in which m
have been gen
netically mo
odified to con
ntain the luxx genes whicch when exprressed in a vviable
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microorganism results in bioluminescence (D'Souza 2001). A successful bioreporter
consists of the appropriate selection of a microorganism that can survive the
environmental conditions under study and the bioluminescent genes must be genetically
incorporated into the target microorganisms without compromising essential cellular
functions (Simpson et al. 1998).
Bioreporters have tremendous applications in food safety. Ripp et al. (2008)
developed a bacteriophage which is able to detect extremely low levels (1 CFU/ mL) of
Escherichia coli O157:H7 in artificially contaminated food samples such as apple juice,
tap water and spinach leaf rinsates. Also, the development of a bioluminescent strain of
Pseudomonas fluorescens 5RL (King et al. 1990) allowed the in situ monitoring of
gaseous chlorine dioxide disinfection whereas the higher the levels of ClO2, the faster
decrease in detectable luminescence (del Busto-Ramos et al. 2008). Another application
is to determine the survival of microbial populations as well as information on the
bacterial spatial distribution on/in a specific food sample. This application of bacterial
luminescence will help to identify hot-spots for contamination based on light emission
intensity (Morrissey et al. 2013). With this being said, bioluminescence-based assays
offer a sensitive, real-time, accurate, and spatial methodology for monitoring the presence
and behavior of bacterial population in food samples (D'Souza 2001, Morrissey et al.
2013).
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2.2.1 Bacterial lluciferase
The bacterial lucifferin is a red
duced riboflaavin phosphaate (FMNH2 ) which is
xidized in asssociation with
w a long-ch
hain aldehydde, oxygen aand a luciferaase (Hastinggs
ox
1983)

Figure
F
2. Ch
hemical Stru
ucture of thee bacterial lluciferin (FM
MNH2). An FMNH2
molecule
m
is oxidized in asssociation with
w a long-chhain aldehydde, oxygen aand a luciferaase
reesulting in th
he release off a photon. Source: (Widdder 2010)
The bacterial lucifferase cataly
yzes the oxiddation of FM
MNH2 and a llong chain
alldehyde (RC
CHO) resultin
ng in a long chain acid ((RCOOH) annd an oxidizzed flavin (FMN)
(H
Hastings and
d Nealson 19
977, Shimom
mura 2012, W
Wilson and H
Hastings 20113). Luciferaase
caatalyzed lum
minescence iss shown in th
he followingg equation:

Equatiion 2
The en
nzyme reactts first with FMNH
F
orm a reduceed enzyme ((Intermediatee 1).
2 to fo
The
T reaction is followed by
b a quick reeaction withh molecular ooxygen creatting a reduceed
en
nzyme-oxyg
gen adduct (IIntermediatee 2), which reeacts with thhe aldehyde resulting in a
reeduced enzyme-oxygen--aldehyde-co
omponent (Inntermediate 3) and light emission at 490

9
nm
m. (Hastingss and Gibson
n 1963, Heittzer et al. 1998). Howeveer, in the abssence of oxyygen,
th
he bacterial luciferase
l
sy
ystem can bee triggered byy the additioon of aldehydde to the
in
ntermediate reduced
r
flav
vin peroxide (Hastings annd Gibson 1963).
The biochemical and
a molecular reactions involved in the bioluminescent cyclle are
sh
hown in Figu
ure 3.

Figure
F
3. Bio
ochemical pathway for bacterial lu
uminescencee (Redrawn
n by K.
Farrokhzad
F
2010). Visib
ble light at 490
4 nm is prooduced in prresence of A
ATP, FMNH2, and
ox
xygen by thee activity off transferase, synthetase rreductase, annd luciferasee.
In the laboratory, a useful bioluminescentt reporter sysstem is madee up of five
sttructural gen
nes: The luxA
AB genes enccode the hetterodimeric lluciferase. W
Whereas the luxC,
lu
uxD and luxE
E encode a reductase,
r
a transferase,
t
aand a syntheetase respecttively. They
work
w
togetherr as a multieenzyme to sy
ynthesize andd recycle thee aldehyde inn an ATP- annd,
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NADPH-depe
N
endent reacttion (Figure 4).
4 In naturaally-occurrinng biolumineescent bacterria,
th
he aldehyde substrate is synthetized by the fatty acid biosyntthesis pathw
way (Meighenn
1991, Heitzerr et al. 1994)).

Figure
F
4. Exp
pression of the lux gene cassette (lluxCDABE)) in bacteriaal luciferasee. The
lu
uxCDABE iss composed of
o five geness under a sinngle operon. These geness are responssible
fo
or light prod
duction, aldeh
hyde converrsion and alddehyde reusee.

2.3
3

Nanoemuulsions

Emulsio
ons are liquiid-liquid disp
persions of ttwo immisciible liquids ((e.g. water annd
oil). One phase is dispersed in a contiinous phase in the form of droplets ((Terjung et aal.
ng of oil droplets disperssed in acontiinuous waterr phase, is
2012). A systtem consistin
m where waater droplets are dispersed in
denominated oil-in-waterr (O/W) wheereas a system
a continuous oil phase, is known as a water-in-oill (W/O) emuulsion (McC
Clements andd Rao
2011). There are several well-known
w
food emulsiion systems (e.g: mayonnnaise, milk,
g, butter). Acccording to Weiss
W
et al. (2009) emuulsions are traaditionally
saalad dressing
manufactured
m
d on a comm
mercial scale with dropletts in the miccron-size rannge with a
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diameter range from 0.1 µm to 100 µm. These emulsions are usually optically turbid or
opaque because their droplet sizes have similar dimensions to the wavelength of light (r ≈
λ) and so they can scatter light strongly (McClements and Rao 2011). Nowadays, due to
the ultra-high-pressure technologies, emulsions with particles sizes in the nano-size range
(r: 10- 100 nm) can be manufactured. These are called nanoemulsions and they have
shown better stability to gravitational separation and aggregation than traditional
emulsions due to their smaller particle size. However, these systems are still
thermodynamically unstable and phases will tend to separate over time (McClements and
Rao 2011) Nanoemulsions differ from conventional emulsions in their appearance,
physicochemical stability, and texture, making them more suitable for delivering
encapsulated bioactive compounds (Weiss et al. 2009). It is worth noting that there is no
specific critical particle size dependence on the functional properties of nanoemulsions
(Weiss et al. 2009). However, emulsions appearance are highly dependent on particle size
as they become translucent when the diameter is below 90nm. In the food industry, this
physical property is crucial when manufactures need to add antimicrobials or flavors to a
beverage without compromising transparency (Weiss et al. 2009) (Table 2)
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Table
T
2. Com
mparison off thermodyn
namic stabillity and phyysicochemiccal propertiees of
co
olloidal disp
persions preepared with
h oil, water aand emulsiffier.
System
Droplett
Therm
modynamic
Surfacee-to-mass Optical
Radius
Stabiliity
Ratio (m
m2/g
properties
particlees)
Emulsion
E
100 nmUnstab
ble
0.07 – 770
Turbid/Opaaque
100µm
Nanoemulsio
N
n 10 - 100
0
Unstab
ble
70 – 3300
Clear/Turbiid
nm
Microemulsio
M
on 2 – 100
Stable
330 – 13300
Clear/Turbiid
nm
Source: (McC
Clements an
nd Rao 2011
1)

2.3.1 Nanoemulsi
N
ion stability

2.3.1.1 Grav
vitational sep
paration
In con
nventional em
mulsions, grravitational sseparation iss caused by iinstability annd
reesults in creaaming or sed
dimentation. Creaming ooccurs when droplets havve lower dennsity
th
han the contiinuous phasee, therefore, they move uupward and it is more likkely to happpen in
O/W
O emulsio
ons. Whereass sedimentation is a dow
wnwards dispplacement inn W/O emulssion
because miceelles have hig
gher density than the surrrounding phhase (McCleements and R
Rao
2011). Accorrding to Weiiss et al. (200
09), emulsioon stability too gravitationnal separatioon
ncreases as droplet
d
size decreases
d
an
nd creaming velocity is pproportional to d2, where d is
in
th
he diameter of
o the dropleet. If droplett size has a ddiameter arouund 100nm oor less, it wiill be
kinetically staable for man
ny years. Witth this beingg said, nanoeemulsions exxhibit an
im
mprovementt on shelf staability againsst gravitationnal separatioon due to thee entropic driiving
fo
orces and, co
onsequently the droplets can be susppended in thee continuouss phase for loonger
periods of tim
me (Mason ett al. 2006).
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2.3.1.2 Ostw
wald ripening
g
As particle size deecreases, thee solubility oof the encapssulated oil inncreases.
Therefore,
T
theere is more concentratio
c
n of solubiliized oil moleecules in thee surroundingg
aq
queous phasse of a largerr particle thaan in a largerr one.This cooncentrationn gradient is tthe
drriving force that leads sm
mall particlees to move arround largerr ones creatinng diffusion of
en
ncapsulated oil, and even
ntually, an in
ncrease in m
mean droplett size (Tadros et al. 20044,
McClements
M
2011, McCllements and Rao 2011).
2.3.1.3 Drop
plet aggregation
Dropletts in emulsio
ons are consttantly collidiing among eeach other’s due to the
efffects of therrmal energy, gravity and
d applied meechanical forrces. Dependding on the
atttractive or repulsive
r
forrces between
n droplets theey will remaain aggregateed or separatted
reespectively (McClement
(
ts 1999, Horn
n and Riege r 2001). Flocculation is when two or
more
m
particles merge togeether to form
m an aggregaate maintainiing their inddividual integgrity
whereas
w
coaleescence is th
he process where
w
two or more particlles come toggether to create
on
ne single and larger drop
plet.
p
byy small dropllet sizes thuss the system
m
Floccullation of the droplets is prevented
reemains dispeersed with no
o separation (Tadros et aal. 2004). Thhe amount off repulsive
in
nteractions (ee.g. steric, electrostatic) and attractivve interactioons (e.g. Vann der Waals,
depletion) aree reduced wiith decreasin
ng droplet sizze (Weiss ett al. 2009).
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2.3.1.4 Bioaactive solubiility
The maajor issue wh
hen using anttimicrobial eessential oilss in foods is the large
am
mounts that need to be added
a
due to their low w
water solubiliity which cann interfere w
with
th
he food prod
duct’s sensorry characteristics (Gaysinnsky et al. 2008). Thereffore, the
nanoencapsullation of thesse phytophen
nols is an effficient way of increasingg their solubbilty.
Nanoencapsu
N
ulation also in
ncreases theeir physical sstability by pprotecting thhem from thee
in
nteractions with
w food ing
gredients as well
w as increeasing their bbioactivity tthrough the
acctivation of passive
p
mecchanisms of cell
c absorptiion (Weiss eet al. 2009).

2.3.2 Nanoemulsio
N
ons as naturaal antimicrobbial vehicless
Nanoeencapsulatio
on is an efficient alternattive to deliveer bioactive ccompounds by
in
ncreasing theeir solubility
y and keeping them stablle over time.. Due to the small particle
siizes, nanoem
mulsions can increase ph
hysical stabillity of the biooactive com
mpounds,
prrotecting theem from inteeractions witth food ingreedients and iimproving bioavailabilitty
(D
Donsì et al. 2011).
2
In add
dition, nanoeemulsions hhave been useed to deliverr antimicrobials
to
o ensure safeety and qualiity of foods (Parris et al.. 2005, Jang and Lee 20008, Luo and
Stutzenbergerr 2008, Donsì et al. 2011
1). Previous studies havee shown thatt encapsulateed
an
ntimicrobialls are more effective
e
agaainst food-boorne pathogeens than puree compoundss
(D
Donsì et al. 2011,
2
Liang et al. 2012).
Nanoeencapsulatio
on of terpenees from Melaaleuca alternnifolia weree tested on orrange
an
nd pear juicees inoculated
d with Lacto
obacillus dellbrueckii; deelay of antim
microbial grow
wth
was
w achieved
d with 1g/L terpenes and bacterial inaactivation w
was successfuul with 5g/L
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terpene (Donsì et al. 2011). The mechanism by which antimicrobials loaded in
nanoemulsions successfully inhibit antimicrobial growth depends on the nature of the
encapsulated component (e.g. essential oil, protein, surfactant), and also, on the
characteristics of the nanoemulsions themselves (e.g. size, charge, composition)
(McClements and Rao 2011). For example, the lipid phase of the nanoemulsion can be
loaded with a non-polar antimicrobial for further delivery by mass transport of the
antimicrobial from the inside of the emulsion through the aqueous phase of the food
system to the membrane of the pathogen (Weiss et al. 2009). Basically, these delivery
systems must be antimicrobial reservoirs ensuring constant concentrations in the aqueous
phase during time. This function is extremely important based on the lower solubility of
essential oils, therefore, the amount of the antimicrobial in a certain water volume would
be very limited (Donsì et al. 2011). According to McClements et al (2011) when droplet
sizes are smaller in oil-in-water (O/W) nanoemulsions, the oil-water surface area
increases leaving more lipid phase exposed to the surrounding aqueous phase; therefore,
they are more susceptible to chemical degradation due to oxidation or hydrolysis of the
antimicrobial. It is recommended to store the nanoemulsions in a dark place because
chemical degradation can be accelerated by UV or visible light which can penetrate them
more easily due to their small size.
Likewise, it is essential to choose an antimicrobial that will be capable of
exhibiting its desired functional properties under the conditions of the nanoemulsion
production, storage, and usage (McClements 1999). However, the biggest disadvantage
of using nanoemulsions to encapsulate bioactive compounds is that the equipment
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required (homogenizer, microfluidizer, and ultrasonicator) is expensive, therefore a large
amount of initial monetary infusion is necessary (Kumar and Singh 2012).

2.4

Antimicrobial spectrum of herbs and spices

An interest in using natural antimicrobials to prevent food-borne outbreaks is
growing rapidly due to the emerging consumer demand for non-artificial food products,
and as a consequence, food manufacturers are putting efforts into replacing chemical
preservatives with natural and label-friendly antimicrobials extracted from herbs, spices
and/or plants while maintaining microbiological safety (McClements 1999, Smid and
Gorris 1999, Nazer et al. 2005, Tajkarimi et al. 2010).
The main purpose of using spices and herbs in the food industry is usually
flavoring. Their functional properties (e.g. flavor and aroma compounds, and
antimicrobial activity) are found in the essential oils (EOs) which are aromatic oily
liquids, commonly obtained by steam distillation of plant material (Burt 2004).
Antimicrobial agents originally from plants, can be phytoalexins, isothiocyanates,
alliin, plant pigments and phenolic compounds from herbs and spices (Cutter 2000).
Phytoalexins are antimicrobials with low molecular weight, broad-spectrum, and host
synthesized compounds, which are produced when the plant is injured. Isothiacyanates
are stored in the cell vacuoles of plants and their release occurs when tissue is disrupted.
Alliin, is a broad-spectrum antimicrobial and precursor of allicin, it is produced when
plant or bulb tissues are injured (Cutter 2000). Many factors have influence on the
antimicrobial activity of phyto-phenols, such as: chemical composition, geographic origin
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and crop to crop variations (Moyler 1994) as well as characteristics of the target
microorganism such as genus, species, strain, and stage of growth (Naidu 2010).
The effect of natural antimicrobials against food-borne pathogens have been widely
investigated. The antimicrobial effect of the essential oil of eucalyptus (40.5% piperitone,
17.4% α-phellandrene) was tested against Gram positive and Gram negative
microorganisms using the agar diffusion method whereas Staphylococus aureus (Gram
positive) was the most sensitive with an inhibition zone of 52.3 ± 5.6 mm, and
Pseudomona aeruginosa (Gram negative) was the most resistant strain with an inhibition
zone of 9.1 ± 0.3 when 10 µl of the essential oil was added (Gilles et al. 2010). Donsi and
colleagues research has focused on the effect of encapsulating two essential oils, a
mixture of terpenes from Melaleuca alternifolia (commonly known as Narrow-leaved
Tea-tree, which have been used for medical purposes since the colonization of Australia
at the end of the 18th century), and D-limonene into nanoemulsion to enhance their
antimicrobial activity and improve the delivery system and have published 2 reports on
this topic. In their 2011 study, they concluded that all minimal inhibitory concentrations
(MIC) against E. coli, L. delbrueckii and S. cerevisae where lower when the antimicrobial
was encapsulated in comparison to the non-encapsulated compound. They also
investigated the antimicrobial activity of an encapsulated mixture of terpenes against L.
delbrueckii in pear and orange juices. Results showed that 1.0g/L of terpenes was needed
to inhibit microbial growth and 5.0g/L was needed to completely inactivate the
microorganisms without changing the organoleptic properties of the fruit juices (Donsì et
al. 2011). Based on these results, Donsi et al. (2012) investigated the antimicrobial effect
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of nanoencapsulating carvacrol, limonene and cinnamaldehyde into sunflower oil
droplets stabilized with different emulsifiers (lecithin, pea proteins, sugar ester, and
combination of Tween 20 and glycerol monooleate). The results proposed that the
efficiency of the antimicrobials is positively related with its concentration in the aqueous
phase which is ruled by the effect of the emulsifier, whereas emulsions with Tween 20
and glycerol monooleate has a higher bactericidal activity in less than 2h (Donsi et al.
2012). The antimicrobial activity of the essential oil of lemon myrtle, mainly formed by
citral, was tested against fifteen different types of microorganisms including yeasts, fungi,
Gram positive and Gram negative bacteria. Lemon myrtle samples were prepared in
different ways to test differences in antimicrobial activities: 1) tea was infused in boiling
water, 2) tea was infused in water at 45°C to prevent loss of any antimicrobial activity
through evaporation, 3) tea was prepared ten times more concentrated than manufactures
recommendation in boiling water (10X= 5g of tea leaf in 25 mL of water), and 4) the
effect of citral alone was conducted as a control. The concentrated sample was an
effective antimicrobial against all microorganisms and no differences between Gram
positive and Gram negative were identified (Wilkinson et al. 2003).
Although the comparison of results concerning the antimicrobial activity of natural
herbs and spices is challenging due to the differences in methods, bacterial strains,
antimicrobial concentrations and contact time (Burt 2004), it has been proved that the
amount of essential oil needed to effectively inactivate microorganisms in vitro is much
lower than the quantity required to achieve the same results in a food system (Burt 2004,
Devlieghere et al. 2004, Gutierrez et al. 2008). In addition, gram positive strains have
shown to be more susceptible to the antimicrobial effect of essential oils than gram
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negatives (Tassou and Nychas 1995, Mendoza-Yepes et al. 1997, Lambert et al. 2001,
Gilles et al. 2010).
Burt (2004) conducted an extensive review on essential oils and their antibacterial
properties with various food systems and concluded the following ranking of essential
oils from higher bactericidal effect to lower: oregano/ clove/ coriander/ cinnamon>
thyme> mint> rosemary> mustard> clinatro/ sage. The components of the essential oils
were also a ranked and reported as to their bactericidal effect as well: eugenol> carvacrol/
cinnamic acid > basil methyl chavicol> cinnamaldehyde> citral/ geraniol. Table 3
exhibits the antimicrobial composition of several EO.
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Table 3. Antimicrobial composition of different EO.
Essential oil
Latin name of plant
Major
source
component
Cilantro
Linalool
Coriandrum sativum
(immature leaves)
E-2-decanal
Coriander
Linalool
Coriandrum sativum
(seeds)
E-2-decanal
Cinnamon
TransCinnamomum
cinnamaldehyde
zeylandicum
Oregano
Origanum vulgare
Carvacrol
Thymol
ϒ-terpiene
p-Cymene
Rosemary
α-pinene
Rosmarinus officinalis
Bornyl acetate
Camphor
1,8-cineole
Sage
Salvia officinalis L.
Camphor
α-pinene
β-pinene
1,8-cineole
α-tujone
Clove
Eugenol
Syzygium aromaticum
Eugenyl acetate
Thyme
Thymol
Thymus vulgaris
Carvacrol
ϒ-terpiene
p-Cymene
Mint
Carvone
Mentha spicata
(Govindarajan et al.
cis-Carveol
2012)
Limonene
1,8-cineole
Mustard
Allyl
Brassica juncea
isothiocyanate
(Kirk et al. 1964)
Allyl
thiocyanate
Source: (Burt 2004)

Approximate
% composition
26%
20%
70%
--65%
Trace-80%
Trace-64%
2-52%
Trace-52%
2-25%
0-17%
2-14%
3-89%
6-15%
4-5%
2-10%
6-14%
20-42%
75-85%
8-15%
10-64%
2-11%
2-31%
10-56%
48.60%
21.30%
11.30%
2.55%
90.50%
9.50%
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2.4.1

Carvaacrol

Carvaacrol is a monoterpenic phenol
p
isomeeric with thyymol (Laurinn and Stuparr
m
in orregano essenntial oil (60 tto 74%) and in
1986) (Figuree 5). Carvacrrol is found mainly
th
hyme (45%). This antim
microbial has been granteed GRAS (G
Generally Reccognized Ass Safe)
by
y the FDA and
a its regulaations are un
nder the Codde of Federall Regulationns Chapter 211,
part 172: Foo
od additives permitted
p
fo
or direct addiition to foodd for human cconsumptionn
(B
Burdock 201
10).The max
ximum levelss that carvaccrol can be addded to certaain food
prroducts are: baked good
ds (15.75 ppm
m), chewing gum (8.42 pppm), condim
ments (18 pppm)
(U
Ultee et al. 1999,
1
Burdocck 2010). Ho
owever, the uuse of this pphenolic com
mpound as
prreservative in
i food prod
ducts is someetimes limiteed due to flavvor considerrations.
Therefore,
T
theere is a urge to find an accurate/effec
a
ctive minim
mal inhibitoryy concentratiion
(M
MIC) in diffferent food sy
ystems without comprom
mising the seensory aspeccts (Lambertt et al.
2001).

Figure
F
5. Ch
hemical stru
ucture of carrvacrol and thymol. Booth compounnds are
monoterpenic
m
c phenols and are isomerrs. Their watter solubilityy have been rreported to bbe
1.25g/L at 20
0°C (Chen ett al. 2014)
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The efficiency of carvacrol as food antimicrobial has been tested (Lambert et al.
2001, Ultee et al. 2002, Ben Arfa et al. 2006). Arfa et al. (2006) compared the
antimicrobial activity of five different aroma compounds (carvacrol, carvacrol methyl
ester, carvacryl acetate, eugenol, menthol) concluding that the chemical structure of
carvacrol is benefited by the hydroxyl group, which made carvacrol more efficient than
the other compounds. These results are comparable with the study conducted by Ultee et
al. (2002) when testing carvacrol, thymol and menthol against Bacillus cereus. The
activity of thymol (having a hydroxyl group in the meta position) was effective at
minimal concentrations of 0.75 mM and was similar to carvacrol. Menthol, on the other
hand, that does not have a hydroxyl methyl group was approximately 10 times less
effective than carvacrol. However, when carvacrol was tested in fish samples, the
antimicrobial activity was lower due to interactions with the food matrix (Kim et al.
1995). A partially synergistic effect against oral bacterial strains of Streptococcus and
Prevotella was observed when combinations of carvacrol with thymol and, carvacrol with
eugenol, resulted in Fractionary Inhibitory Concentrations (FIC) between 0.5 and 0.75.
The FIC ranking is divided in sections: FIC ≤ 0.5 (total synergism), 0.5 < FIC ≤ 0.75
(partial synergism), 0.75 < FIC ≤ 2.00 (no effect), and FIC > 2 (antagonism) (Didry et al.
1994). In contrast, the synergistic effect of carvacrol and p-cymene (0.30mg/g and
0.27mg/g respectively) against B. cereus, was reduced when salt was added to rice
samples (1.25 g salt/L of rice) (Ultee et al. 2000).
The following two sections are divided in emulsifiers and lipids, which are crucial
components of nanoemulsions. Particularly, the emulsifier section will be focused on
Lecithin and Tween 20 which are used in the present study. On the other hand, the lipid
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piece includes a description of coconut oil and palm stearin since they are utilized in this
study.

2.5

Emulsifiers

A strong interfacial tension exists between both the water and the oil phase,
therefore, nanoemulsions are thermodynamically unstable and must be stabilized by
adding emulsifiers which adsorbs at the interfaces and reduce the interfacial tension (Mao
et al. 2010). As a result, association colloids (or micelles) are formed where the
unfavorable contact area between the non-polar tails of the surfactant and water is
minimized. Consequently, addition of emulsifiers is essential to improve emulsion
formation, enhance stability against coalescence or flocculation, and reduce the particle
size needed to create nanoemulsions (Weiss et al. 2009).
Emulsifiers are molecules which consist of hydrophilic/lipophobic and
lipophilic/hydrophobic parts. They are categorized mainly by their hydrophilic/lipophilic
balance (HLB) (Whitehurst 2008) which is summarized in the equation below:

HLB = 20* (M0/M)

Equation 3

Where M0 is the molecular weight of the hydrophilic part of the emulsifier
molecule and M is the total molecular weight. There are different uses depending on the
HLB value: 0-3: antifoaming agents, 4-6: water-in-oil emulsifier, 7-9: wetting agent, 8-18:
water-in-oil emulsifier, 13-15: detergents, and 10-18: solubilizes (Whitehurst 2008).
Table 4 shows what type of emulsifier should be used in different food products based on
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their functionality. Before a food emulsifier is legally allowed for use in food products it
has to be tested in several toxicological studies. Emulsifiers are regulated by the Joint
Expert Committee on Food Additives (JECFA) of the Food and Agricultural
Organization/World Health Organization (FAO/WHO) (Friberg et al. 2003).
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Table 4. Functionality of surfactants in some foods. The hydrophilic/lipophilic balance
(HLB) of an emulsifier will determine their functionality in food products
Functionality
Surfactant
Food examples
Foam aeration/stabilization

Propylene glucol esters

Cakes, whipped toppings

Dispersion stabilization

Mono/diglycerides

Peanut butter

Dough strengthening

DATEM

Bread, rolls

Starch comlexation (anti-

SSL, CSL

Bread, other baked goods

Clouding (weighting)

Polyglycerol esters, SAIB

Citrus beverages

Crystal inhibition

Polyglycerol esters,

Salad oils

staling)

oxystearin
Antisticking

Lecithin

Candies, grill shortenings

Viscosity modification

Lecithin

Chocolate

Controlled fat

Polysorbate 80,

Ice cream, whipped

agglomeration

polyglycerol esters

toppings

Freeze-thaw stabilization

SSL, polysorbate 60

Whipped toppings, coffee
whiteners

Gloss enhancement

Sorbitan monoestearate,

Confectionary coatings,

polyglycerol esters

canned and moist pet
foods

Source:(Hasenhuettl 2008)
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2.5.1

Lecithin

Lecithin is commercially isolated from either soybean or sunflower by solvent
extraction and subsequent precipitation. The hydrophilic component of lecithin is the
phosphatidyl group, whereas two fatty acid chains are the hydrophobic side (Hasenhuettl
2008). Lecithins are considered zwitterionic surfactants since they have both positively
and negatively charged groups on the same molecule. In many cases, lecithin is an ideal
biological emulsifier because it is biodegradable, acquired GRAS status, and researchers
agree that addition of lecithin decreases emulsion particle size (Mao et al. 2010, Donsi et
al. 2012). There is a variety applications of lecithin nanoemulsions. In pharmaceutics,
lecithin increases skin hydration penetration due to the greater partitioning degree into the
stratum corneum (top layer of epidermis) (Zhou et al. 2009). In the food industry, the use
of marine lecithin nanoemulsions increases considerably the stability of salmon oil
against oxidation (Belhaj et al. 2010). The addition of lecithin to chocolates and coatings
reduces noticeably the viscosity due to its hydrophilic sugar crystal surface (Hasenhuettl
2008).

2.5.2

Tween 20

Tween emulsifiers have a polysorbate structure, are amphipathic, nonionic and they
acquire a number on their nomenclature depending on the type of fatty acid ester
associated with the polyoxyethylene sorbitan. For example, Polysorbate 20
(polyoxyethylene sorbitan monolaurate) and Polysorbate 80 (polyoxyethylene sorbitan
monooleate) (Kerwin 2008). Non-ionic surfactants are commonly chosen because of their
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stability to pH and changes in ionic strength (Azeem et al. 2009). According to Donsi et
al. (2012) the combined use of Tween 20 and glycerol monooleate as surfactants, causes
the measured aqueous-phase concentration of carvacrol, limonene and cinnamaldehyde to
be 4 times, 20 times and 4-to-6 folds higher than its water solubility respectively. Also,
Tween 20 (1-2% wt) combined with caseinate (1-2% wt) have the ability to reach
sufficient surface-active material to saturate the droplet interface without inducing
flocculation by excess of protein and emulsifier (Dickinson et al. 1999). It has been
reported that an increase in Tween 20 concentration resulted in a lineal improvement on
curcumin solubility reaching an upper limit of 294 µM curcumin with 0.05 w/v% Tween
20 (O’Toole et al. 2012). Since Tween 20 is a nonionic surfactant, its binding with
compounds such as nisin and zein weakens hydrophobic attraction and improves the
release of nisin from capsules (Xiao et al. 2011).

2.6

Oil Phase

The stability and formation of nanoemulsions depend on the physicochemical
characteristics of the oil phase such as: polarity, water-solubility, interfacial tension,
refractive index, viscosity, density, phase behavior, chemical stability (McClements and
Rao 2011), and good solvent capacity (Sanghi and Singh 2012). Several non-polar
compounds can be used to prepare nanoemulsions, e.g. triacyglycerols (TAG),
diacyglycerols, monoacyglycerols, free fatty acid, flavor oils, essential oils, and mineral
oils, among others. (McClements and Rao 2011). The oil phase can sometimes act as a
solvent for various important food components, including oil-soluble vitamins,
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antioxidants, preservatives and essential oils (McClements 1999, Azeem et al. 2009). In
food emulsions, the oil phase plays a critical role on texture. For example, “spreadability”
on margarines is determined by a three-dimensional network formation of fat crystals in
the continuous phase, which provides mechanical rigidity (McClements 1999).

2.6.1

Coconut Oil

Coconut oil (CO) is one of the most widely used confectionary fats with a simple
TAG composition of 90% saturated fatty acids. (Chaleepa and Ulrich 2011). It is the most
important oil crop in tropical regions and is extensively used for food and industrial
purposes (Sriamornsak et al. 2012). CO has been successfully applied to chitosan edible
composite films at a CO/chitosan ratio of 0.5 to 1, above which phase separation was
observed during the drying process (Binsi et al. 2013). Also, CO provided the smallest
particle size (100-500 nm) when tested against sunflower and castor oils in a system
where the emulsifier was a combination of polysorbate 80 and sorbitan monooleate 80
(Sriamornsak et al. 2012). Due to its high fatty acid content, particles interfaces acquired
a multi-lamellar structure (Lee et al. 2011).

2.6.2

Palm Stearin

Palm stearin (PS) is obtained by fractionation of palm oil which results in
approximately 62.7% of palmitic acid content which makes it suitable for several
industry applications: the addition of PS to hydrogenate palm kernel oil (HPKO) in a
ratio of 66:34 HPKO:PO increases the performance and stability of whipping cream
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(Nesaretnam et al. 1993). Also, by combining PS with palm olein the solid fat content
(SFC) profile improved resulting in smoother margarines and spreads (Wassell and
Young 2007). PS have diverse melting, crystallization, and polymorphic transformation
temperatures which increase confounds the understanding of its polymorphism in
comparison to simple TGA (Sonoda et al. 2004). However, the crystallization and
polymorphic transformation of PS in nanoemulsions can be modified by using
polyglycerine fatty-acid esters (Sonoda et al. 2006).
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CHAPTER 3. EFFECT OF CARVACROL-LOADED NANOEMULSIONS ON A
BIOLUMINESCENT STRAIN OF ESCHERICHIA COLI O157:H7

3.1

Abstract

Nanoemulsions have been shown to be effective delivery vehicles for natural
antimicrobials that are poorly soluble in water. The antimicrobial activity of carvacrol (5isopropyl-2-methylphenol) nanoemulsions against a bioluminescent Escherichia coli
O157:H7 was investigated using light emission as an indicator of cell viability. Different
emulsifiers (Ultralec Lecithin and Tween 20), oils (Palm stearin and Coconut oil) and
various carvacrol emulsion concentrations (0, 1, 2 and 2.5%) were evaluated.
Bioluminescence response was monitored in situ using a Hamamatsu (photo multiplier
tube) sensor module integrated with a Programmable Logic Controller interfaced with a
PC for data acquisition. Bioluminescence decreased rapidly with the addition of
carvacrol-containing nanoemulsions. However when cells were assayed for viability,
plate counts showed the bacteria were not inactivated suggesting that the carvacrol was
interfering with the luminescence reaction. To determine if the process was reversible,
carvacrol was removed from the bacteria after five min of contact time by centrifugation
and cells were resuspended in minimal media with glucose as a carbon source. Light
values recovered to levels higher than prior to the addition of carvacrol indicating
reversibility.
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The same bioluminescent pattern was also observed with sub lethal doses of the
oxidative uncoupler 2,4-dinitrophenol. These results suggest that carvacrol and 2,4-DNP
uncouple oxidative phosphorylation reducing the ATP available for the myristyl aldehyde
biosynthesis. Previous reports suggested that the mechanism of inactivation of carvacrol
was membrane damage resulting in loss of cellular contents and viability. However these
results suggest that the mechanism of carvacrol inactivation is due to the uncoupling of
oxidative phosphorylation.

3.2

Introduction

There is an increasing interest of consumers in natural substances which has
focused the attention on plants containing bioactive compounds such as Essential oils
(EOs) due to their antimicrobial, antioxidant and antiradical properties (Cutter 2000, Ben
Arfa et al. 2006, Chang et al. 2013). EOs are aromatic oily liquids produced in plants as
secondary plant metabolites. They are responsible for the odor, aroma and flavor of
spices and herbs (Cutter 2000). EOs are commonly extracted by steam distillation
(Bakkali et al. 2008). Besides antimicrobial activities, EOs have shown antiviral,
antimycotic, antitoxigenic, antiparasitic and insecticidal properties (Burt 2004). Some
preservatives containing EOs are currently commercially available. Mendoza-Yepes et al.
(1997) reported that ‘DMS Base Natural’ (DOMCA S.A., Alhendin, Granada, Spain) is a
food preservative that contains 50% glycerol and 50% essential oils from rosemary, sage
and citrus. Isman (2000) reported that Cinnamite TM an aphidicide, miticide and fungicide
for horticultural crops and Valero TM, a miticide and fungicide in grapes, berry crops,
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citrus and nuts (both manufactured by Mycotech Corp. Butte, MT, USA) contain
cinnamon oil and 30% of cinnamaldehyde as the active ingredient. On the other hand,
Cutter (2000) reported that ‘Protecta one’ and ‘ Protecta two’ (Bavaria Corp. Apopka, FL,
USA) are food additives with the GRAS Status (Generally Recognized as Safe), that
contain essential oils dissolved in solutions of sodium citrate and sodium chloride,
respectively.
Carvacrol (5-isopropyl-2-methylphenol) is a naturally occurring compound,
abundant in the essential oil fraction of oregano (60 to 74% carvacrol) and thyme (45%
carvacrol) (Ultee et al. 1999). Its antimicrobial properties on foods and other systems has
been widely investigated (Ben Arfa et al. 2006, Ait-Ouazzou et al. 2011, Terjung et al.
2012). In comparison to other naturally occurring compounds, carvacrol has better
antimicrobial properties than eugenol, menthol, carvacrol methyl ether and carvacryl
acetate (Ben Arfa et al. 2006). However, the mechanism of action of this compound is
still being investigated (Ultee et al. 1999, Lambert et al. 2001). Nevertheless, some
authors have proposed that it may act through disruption of membrane integrity,
increasing proton permeability by releasing cellular constituents (Sikkema et al. 1994,
Ultee et al. 1999, Lambert et al. 2001). Nychas (1995) also proposed that phenols might
alter the physiological status of cells by changing the fatty acid composition and
phospholipid content of bacteria; disrupting the electron transport or nutrient uptake and
affecting nucleic acid synthesis and energy metabolism.
The objective of this study was to evaluate the antimicrobial activity of carvacrolcontaining nanoemulsions and to understand its mechanism of action. Nanoemulsions
were selected as an antimicrobial delivery system since they have been shown to increase
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th
he bioavailab
bility and solubility of lipophilic subbstances. Eveen though naanoemulsionns are
not thermody
ynamically sttable, they have
h
an extreemely long kkinetic stability due to thheir
sm
mall particlee size (50-50
00nm) (Horn
n and Rieger 2001, Terjuung et al. 20112).
Nanoemulsio
N
ns are being
g used in several fields (ee.g. formulattion of pigm
ments, producction
of catalysts an
nd pharmaceeutical applications) (Hoorn and Riegger 2001, Accosta 2009), and
arre promising
g for the deliivery of bioaactive compoonents in foood products (Ubbink andd
Krüger
K
2006))

3.3

3.3.1

Materials
M
annd methods

Naanoemulsionns formulatioon

Nanoeemulsion forrmulation co
ontains 94.5%
% (w/w) of w
water, 0.5% (w/w) of
su
urfactant (Leecithin Ultraalec or Tweeen 20) and 5%
% (w/w) of llipid phase. The lipid phhase
was
w prepared
d by mixing 5,
5 4, 3 or 2%
% (w/w) fat ( coconut oil oor palm steaarin) with 0, 1, 2
orr 2.5 % (w/w
w) carvacrol in order to maintain
m
thee 9.5:0.5 aquueous phase: lipid phase ratio
co
onstant. Thee nomenclatu
ure used to id
dentify eachh formulationn is shown inn Figure 6

Figure
F
6 Nom
menclature used for diffferent form
mulations off nanoemulssion. Differeent
oils (Coconutt oil or palm stearin), surrfactants (leccithin or tweeen 20) and ccarvacrol
co
oncentration
ns (0, 1, 2, orr 2.5%) weree used creatiing sixteen ddifferent form
mulations weere
94
4.5% was water,
w
0.5% surfactant, 5%
% lipid phasse including carvacrol.
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3.3.2

Bacterial strain and media

A bioluminescent, kanamycin and ampicillin resistant strain E. coli O157:H7 lux
was constructed by cloning the bioluminescent gene cassette (luxCDABE) from
Photorhabdus luminescence into a pCRII cloning vector (Invitrogen, Carlsbad, CA) by
Dr. Linda Perry. The resulting plasmid, pFSP102, was inserted into E. coli O157:H7
strainC7927, an acid tolerant strain isolated from an apple cider outbreak. The
constructed strain has the ability to emit light at 490 nm in presence of oxygen and
FMNH2. E. coli O157:H7 lux was grown in a continuous culture using minimal salt
media (MSM) (0.068% monopotassium phosphate, 2.2% dipotassium phosphate; 0.1%
magnesium phosphate; 2% ammonium nitrate, Sigma®) supplemented with glucose (500
ppm), kanamycin (50mg/mL), and trace elements (0.01w/v%) (Heitzer et al. 1990)

3.3.3

Chemostat setup

A sterile 16 liter carboy containing sterile media was connected to a previously
sterilized bioreactor using a Primary IV set (Direct Pet; 73 inch). Media was pumped into
the bioreactor (Kontes Cytolift Glass Airlift Bioreactor Cell Culture) using a multistaltic
pump (Buchler, 2-6250, New Jersey, U.S.A) at a constant rate of 1.5mL/min. The
bioreactor containing the bacteria was mixed using filter-sterilized air (Pall Life Sciences
Supor® 200, 47 mm, 0.2 µm) at 5 psi using a Fairchild Industrial regulator (Kendal, 19,
North Carolina, U.S.A) (figure 7). The bacterial concentration in the bioreactor was kept
constant at an optical density (OD) of 0.500 measured using a biophotometer (22331,
Eppendorf BioPhotometer, Hamburg, Germany) and light of approximately 17,000,000
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RLU/s
R
measu
ured using a luminometeer (Zylux Fem
mtomaster F
FB14, D-75173, Pforzheiim,
Germany).
G

Figure
F
7. Ch
hemostat settup. Sterile MSM
M
mediaa with kanam
mycin, glucosse and trace
ellements (A) is pumped by
b a peristalttic pump (B)) at a constannt rate of 1.55 mL/min too a
bioreactor con
ntaining Esccherichia colli O157:H7 llux (C). An excess of baacterial cultuure
du
ue to the con
nstant mediaa pumping iss collected inn a waste conntainer (D). The bacteriaa is
vigorous mixed using sterrile air (E). A port for baacterial colleection is locaated at the toop of
th
he bioreactorr (F).
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3.3.4

In vivo bioluminescence monitoring and cell viability

One mL of bacteria from chemostat was prepared in duplicate. Kanamycin was
removed from the bacterial culture by washing three times with MSM by centrifugation
(Eppfendorf centrifuge 5415D for 10 min at 16,100 g). The bacterial pellet was
resuspended using 10 mL of MSM. Sterilized glass vials (20 mL) were used for each
experiment containing 8.1mL of MSM and 0.9 mL of the previously prepared bacteria.
Finally, 1 mL of diluted emulsion was added to each vial to reach the desired carvacrol
concentration. Bacterial concentration in the vials was about 107 CFU/mL)
Bioluminescence was measured in situ using a photo multiplier tube (PMT)
(Hamamatsu, AC135, Iwata-gun, Japan) sensor module in a light-tight box integrated
with a programmable logic controller interfaced with a PC for data acquisition (figure 8).
Bioluminescence was monitored for ten minutes as follows: photon emission of the initial
bacterial dilution was measured during one min after which, one mL of the emulsion or
decanal was injected to the sample through an inlet tubing using a syringe and photon
emission was recorded every second during nine additional minutes. The mixture was
stirred using a magnetic stirring bar during the duration of the measurement. Immediately,
after measuring bioluminescence, an aliquot of 0.1 mL was serially diluted and plated
onto Luria Broth (LB) agar plates supplemented with kanamycin (50mg/mL) (LB kan)
using the spread plate technique. Samples were incubated overnight at 37°C before
colony counting.
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Figure
F
8. Pho
oto Multiplier Tube (P
PMT) System
m for real-tiime biolumiinescence
monitoring.
m
The PMT Prrogrammable Logic Conntroller (A) iis connectedd to the sampple
vial (B) wherre it is constaantly stirred using a stir pplate (C) Ann inlet vial (D
D) is for sam
mple
in
njection. Thee system is connected
c
to a PC for dat
ata acquisitioon (E). The ssystem is cloosed
an
nd covered with
w black clloth to avoid
d penetrationn of environm
mental light (F).
.
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3.3.4.1 Dosee-response and
a bactericiidal activities (BA50 valuues)
Bacterricidal activiities are defiined as the ppercentage off a test comppound needeed to
in
nactivate 50%
% of the baccteria under test
t conditioons (Friedmaan et al. 20044). Emulsionns
co
ontaining 2.5
5% of carvacrol were tessted at two aadditional cooncentrations: 250 and 350
pp
pm. The perrcentage of killed
k
bacteriia was evaluuated by com
mparing eachh dilution witth
th
he average control value. Dose-respo
onse graphiccs (concentraation of carvvacrol vs % kkilled
bacteria) weree used to dettermine BA50
ssion modelss. The lowerr the
5 values by linear regres
BA
B 50, the higher the antim
microbial acttivity (Friedm
dman et al. 20004).

3.3.5

Effect of carvacrol oon biolumineescence

Bacterrial dilutionss were prepaared as previiously descriibed (sectionn 3.3.4). Glaass
vials were preepared with 0.9 mL of washed
w
bacteeria and 0.1 m
mL of nanoeemulsion. Liight
was
w monitoreed every min
nute for five minutes usinng a luminom
meter (Zyluxx Femtomasster
FB14, D-75173, Pforzheiim, Germany
y). To underrstand if the effect of carrvacrol on phhoton
em
mission wass reversible, the
t antimicrrobial was reemoved by centrifugationn (Eppfendoorf
ceentrifuge 5415D for 10 min
m at 16,10
00 g) after fivve min of coontact time w
with bacteriaa. The
reesulting pelleet was resuspended with
h one mL of MSM contaaining glucosse (1000 ppm
m) as
th
he carbon source. Light was
w monitorred for anothher five addittional minuttes using a
lu
uminometer.
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3.3.6

ATP Assay

To understand if the mechanism of action of carvacrol was interfering the ATP
production, an ATP Swab Hygiene test was performed. An ATP vs light standard curve
was constructed. The initial solution contained 10 mM of ATP (Biolabs, P0756S, Ipswich,
MA, United States) and was serially diluted from 100-10-8 using sterile-filtered distilled
cold water. 100 µL of each dilution was mixed with 100 µL of Clean-Traceᵀᴹ Surface
ATP (3M ,St.Paul, Minessota, United States) reagent (water 70-80%, non-hazardous
components 15-25%, sodium azide <0.1%, luciferase 0.0001-0.0007%, and luciferin
0.0001-0.0006%) and bioluminescence was measured using a luminometer (Zylux
Femtomaster FB14, D-75173, Pforzheim, Germany). To estimate the remaining amount
of ATP after mixing Escherichia coli O157:H7 lux and nanoemulsions an ATP assay was
conducted. Bacteria from the chemostat was washed three times by centrifugation
(Eppfendorf centrifuge 5415D for 10 min at 16,100 g) and the pellet resuspended in
MSM. After the final wash the pellet was resuspended in MSM.
Emulsions were diluted to 500, 750, 1000 ppm carvacrol using filtered-sterilized
deionized water. All assay vials were sprayed with 70% ethanol and dried to ensure a
background level free of ATP. Each sample vial was prepared by mixing 90 µL of the
prepared bacteria with 10 µL of the emulsion at different concentrations (500, 750 1000
ppm). 100 µL of the Clean-Traceᵀᴹ Surface ATP reagent was added to the sample and
bioluminescence was immediately measured using a luminometer (Zylux Femtomaster
FB14, D-75173, Pforzheim, Germany). The amount of ATP was determined from the
lineal regression equation obtained in the standard calibration curve. All experiments
were performed in duplicate.
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3.4

3.4.1

Results and discussion

Evaluation of cell viability

In order to determine the most effective formulation to inhibit the growth of a
bioluminescent strain of E. coli O157:H7, bacteria were surface plated after ten min of
contact time with emulsions previously diluted with sterile water (500, 750, and 1000
ppm), and colonies were enumerated after overnight incubation at 37ºC (table 5). Table 6
summarizes the treatments that successfully inactivated bacteria. When control emulsions
lacking carvacrol, were added to the E. coli O157:H7 lux, no bacterial inactivation was
observed indicating that the surfactant and fat used on each system do not interfere with
bacterial growth. However, emulsions originally containing 2% or 2.5% of carvacrol, and
subsequently diluted to 1000 ppm, were able to inactivate the bacteria. Donsì et al. (2011)
designed nanoemulsions made with either palm or sunflower oil as the lipid phase, and
either lecithin or modified starch (cleargum) as the emulsifier, and tested those emulsions
as antimicrobial vehicles for a mixture of terpenes against Escherichia coli. They found
that a complete bacterial inactivation was achieved at 5000 ppm and a microbial
reduction at 1000 ppm. However, these results are hard to compare to the results that we
obtained, due to the difference in emulsifiers, oils, contact time and bacterial strain.
(Terjung et al. 2012) studied the antimicrobial effect that carvacrol-loaded nanoemulsions
had against Listeria innocua concluding that at 300 ppm a net statis (no growth and no
death) was achieved and at concentrations exceeding 400 ppm, a rapid increase in the
inactivation occurred. Likewise, in this study all nanoemulsions containing 2.5% of
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carvacrol regardless of their nanoemulsion composition revealed a complete bacterial
inactivation with 10 min of contact time when concentrations exceeding 400 ppm were
used (table 6).
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Table 5. Bacterial enumeration in CFU/mL after treatment with carvacrol-loaded
nanoemulsions. Colonies of Escherichia coli O157:H7 lux were enumerated after being
in contact for 10 min with nanoemulsions containing carvacrol (1, 2 or 2.5%) at three
different concentrations (500, 750 and 1000 ppm). This table shows the result divided by
treatments: a) Tween 20, Coconut oil and carvacrol. b) Tween 20, Palm Stearin and
carvacrol. c) Lecithin, Coconut oil and carvacrol. d) Lecithin, Palm stearin and carvacrol.
The initial bacterial concentration was about 107 CFU/mL
a)
Emulsifier

Oil

Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20

Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut

Emulsifier

Oil

Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20

Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin

Carvacrol
(%)
1
1
1
2
2
2
2.5
2.5
2.5

Dilution
(ppm)
500
750
1000
500
750
1000
500
750
1000

Bacterial load
(CFU/mL)
2.60E+06
1.53E+06
1.25E+06
2.83E+06
5.70E+03
0.00E+00
0.00E+00
0.00E+00
0.00E+00

Standard error

Carvacrol
(%)
1
1
1
2
2
2
2.5
2.5
2.5

Dilution
(ppm)
500
750
1000
500
750
1000
500
750
1000

Bacterial load
(CFU/mL)
5.25E+06
2.45E+06
2.05E+06
2.08E+03
0.00E+00
0.00E+00
1.37E+04
0.00E+00
0.00E+00

Standard error

7.07E+05
2.65E+05
7.07E+04
1.26E+06
1.77E+02
0.00E+00
0.00E+00
0.00E+00
0.00E+00

b)

2.12E+05
2.83E+05
3.54E+04
8.31E+02
0.00E+00
0.00E+00
6.29E+03
0.00E+00
0.00E+00
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Table 5. Continued
c)
Emulsifier

Oil

Carvacrol
(%)

Dilution
(ppm)

Bacterial load
(CFU/mL)

Standard error

Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin

Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut
Coconut

1
1
1
2
2
2
2.5
2.5
2.5

500
750
1000
500
750
1000
500
750
1000

4.50E+05
6.53E+05
5.00E+04
8.23E+06
1.50E+05
0.00E+00
4.08E+03
0.00E+00
0.00E+00

7.07E+03
2.49E+05
1.06E+04
2.42E+06
3.54E+04
0.00E+00
1.94E+02
0.00E+00
0.00E+00

Carvacrol
(%)
1
1
1
2
2
2
2.5
2.5
2.5

Dilution
(ppm)
500
750
1000
500
750
1000
500
750
1000

Bacterial load
(CFU/mL)
8.00E+05
5.00E+05
5.00E+04
5.00E+05
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00

Standard
error
3.18E+05
7.07E+04
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00

d)
Emulsifier

Oil

Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin

Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin
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Table 6. Nanoemulsions that completely inactivated bacterial growth. A summary of
the treatments that inhibited bacterial growth after ten min of contact time. The initial
bacterial concentration was about 107 CFU/mL.
Emulsifier

Oil

Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Tween 20
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin
Lecithin

Coconut
Coconut
Coconut
Coconut
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Coconut
Coconut
Coconut
Palm stearin
Palm stearin
Palm stearin
Palm stearin
Palm stearin

Carvacrol
(%)
2
2.5
2.5
2.5
2
2
2.5
2.5
2
2.5
2.5
2
2
2.5
2.5
2.5

Dilution
(ppm)
1000
500
750
1000
750
1000
750
1000
1000
750
1000
750
1000
500
750
1000

Bacterial load
(CFU/mL)
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00

Standard error
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
0.00E+00
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To clarify and have a better understanding on the effect each factor had on the
microbial inactivation, microbiological results were statistically analyzed using SAS 9.3
to find significant differences (ANOVA p<0.05) between factors (surfactant, fat,
carvacrol content and dilution) and pair-wise interactions. Differences between mean
separations were calculated using LSMEANS. Carvacrol concentrations and dilutions
were significantly different with p-values of 0.0011 and 0.0006 respectively (table 7).
Emulsions with 2.5% carvacrol content exhibited the best antimicrobial results in
comparison to those containing 1% and 2% of carvacrol (table 8). In contrast, dilutions of
1000 ppm and 750 ppm were statistically more effective than 500 ppm (table 9). The fact
that no statistical differences were found between emulsifiers is supported by Donsi et al.
(2012) who tested four types of surfactants (Soy lecithin, pea proteins, sugar ester and a
mixure of glycerol monooleate and tween 20) on carvacrol-loaded nanoemulsions against
Saccharomyces cerevisae: No significant effect was found after 2 h of contact time.
The improvement in antimicrobial activity as carvacrol content increased in the
emulsion was also found by Kim et al. (1995) who tested different concentrations of
carvacrol (0.5%, 1.5% and 3%) against fish cubes inoculated with Salmonella
typhimurium over a 4 day storage period, and it was found that a 1.5% carvacrol
concentration, the efficacy of bacterial inhibition was higher during the first two days of
storage but subsequently decreased possibly due to the interactions with food components.
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Table 7. General Linear Model: Analysis of Variance for bacterial enumeration.
Sources with p<0.05 are statistically different. Results were analyzed in SAS 9.3
Statistical Software.
Source

DF

Type I SS

Mean Square

F Value

Pr > F

Emulsifier

1

2.41E+12

2.41E+12

1.4

Oil

1

2.08E+12

2.08E+12

1.21

Carvacrol

2

2.68E+13

1.34E+13

7.75

Dilution

2

2.99E+13

1.50E+13

8.67

Emulsifier*Oil

1

4.74E+12

4.74E+12

2.75

Emulsifier*Carvacrol

2

3.02E+13

1.51E+13

8.75

Emulsifier*Dilution

2

5.74E+11

2.87E+11

0.17

Oil*Carvacrol

2

2.05E+13

1.02E+13

5.94

Oil*Dilution

2

7.56E+12

3.78E+12

2.19

Carvacrol*Dilution

4

2.25E+13

5.63E+12

3.26

0.242
5
0.277
2
0.001
1
0.000
6
0.103
4
0.000
5
0.847
3
0.004
8
0.122
2
0.018
5

Table 8. LSMEANS separation of carvacrol concentrations. Sources with different
letters are statistically different (p<0.05)
Carvacrol (%)

Bacterial LSMEAN

LSMEAN

2.5
2
1

1477.08
975647.92
1468958.33

A
B
B

Table 9. LSMEANS separation of antimicrobial dilution. Sources with different
letters are statistically different (p<0.05)
Dilution (ppm)

Bacterial LSMEAN

LSMEAN

1000
750
500

283333.33
440266.67
1722483.33

A
A
B
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Theoretically, regardless of the initial carvacrol concentration of the emulsions
(i.e. 1, 2 or 2.5%) once they are diluted for evaluation (500, 750 or 1000 ppm), all
emulsions should theoretically have the same quantity of phytophenol available and
therefore, the same antimicrobial activity. However, this hypothesis differs from the
results. There are differences in microbial activity between emulsions that originally have
different carvacrol concentrations even though they were diluted to the same
concentration (500, 750 or 1000 ppm). Terjung et al. (2012) proposed a mechanistic
explanation to these discrepancies in their antimicrobial results as differences in particle
sizes were obtained. Since the same amount of surfactant is used in the construction of
all emulsions, more surfactant will be needed to stabilize interfaces in smaller particles
sizes. Consequently, less micelles would be found in the aqueous phase, and since these
micelles are excellent solubilizers for phytophenols, much less carvacrol would be found
in the aqueous phase. Therefore, smaller nanoemulsions should be less active than larger
ones. However, in our study no differences in droplet particle sizes were found (Personal
communication Veronica Rodriguez ).
Furthermore, the binding of the essential oil in the hydrophobic region of the
micelles (in presence of the emulsifier indeed), allows the movement of the antimicrobial
to the aqueous phase thus increasing the antimicrobial effect. The increased concentration
due to micelles solubilization is due to the hydrophobic interactions between the
phytophenol and the emulsifier (Donsi et al. 2012). Hence, it is possible that
nanoemulsions formulated with higher carvacrol concentrations (i.e. 2.5%) are potentially
being solubilized more easily in the aqueous phase than emulsions with lower carvacrol
concentration (i.e. 1%) in their initial manufacture. As a consequence, a higher
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antimicrobial activity is observed in more carvacrol concentrated emulsions regardless
the final dilution. For example: Emulsions-2.5% and emulsions-1% are diluted to 500,
750 or 1000 ppm. Despite these dilutions, emulsions-2.5% were always more effective
against E.coli O157:H7 lux than emulsions-1%.
3.4.2

In vivo bioluminescence monitoring

To investigate if cell viability could be correlated to the bioluminescence effect,
in vivo measurements were conducted on the bioluminescent bacteria in presence of
nanoemulsions. Meighen (1991) reported that the expression of lux genes in several
bacterial species, can provide a simple and sensitive way for measuring growth and
bacterial distribution. In addition, bioluminescence facilitate the understanding of the
mechanistic effect that antimicrobials have on bacterial cells prior to death. When
nanoemulsion aliquots were added to the bioluminescent strain of E.coli O157:H7, light
decreased to half the initial value immediately after nanoemulsion addition. However, the
original bioluminescence value was recovered gradually over time when emulsions with
no carvacrol were added. Nevertheless, when carvacrol-loaded nanoemulsions were
added to the sample, bioluminescence was completely inhibited regardless of the
concentration of carvacrol. Figures 9, 10 and 11 show the effect on bioluminescence after
addition of 1mL of nanoemulsion containing Palm Stearin (PS), Lecithin Ultralec (Lu)
and carvacrol with 1%, 2% and 2.5% respectively diluted at 500, 750, or 1000 ppm.
Bioluminescent values were standardized to facilitate the analysis and comparison
between graphs. However, table 10 shows the last non-standardized bioluminescent value
detected by the PMT after 10 min of contact time between E. coli O157:H7 and
nanoemulsions. The final values reported for E. coli O157:H7 lux in presence of
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PS|Lu|C0% (no carvacrol) ranged between 1.625,100 photons/s and 4,147,972 photons/s.
However, the average final bioluminescent value of E.coli O157:H7 in presence of
emulsions (PS|Lu|C%) loaded with 1, 2, and 2.5% were 10,613 photons/s, 9,188
photons/s, and 5,522 photons/s respectively. In other words, after ten minutes of contact
time between E.coli O157:H7 and PS|Lu|C1, 2, 2.5% an average reduction of 99.57% (or
2.37 logs), 99.63% (or 2.43 log), and 99.78% (or 2.65 log) was observed respectively.
Graphs for all treatments can be found in the Appendix A and the non-normalized
values on Appendix B. Nanoemulsions containing no carvacrol were used as positive
controls and Escherichia coli O157:H7 lux with in absence of nanoemulsion was used as
negative control.
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Figure 9. Effeect of nanoem
mulsions con
ntaining Pallm Stearin (P
PS), Lecithinn (Lu) and 1% of
d
dilu
utions: 500, 750
7 and 100 0 ppm.
caarvacrol at different

51

Figure 10. Efffect of nanoemulsions containing Paalm Stearin ((PS), Lecithin (Lu) and 22%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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Figure 11. Efffect of nanoemulsions containing Paalm Stearin ((PS), Lecithin (Lu) and 22.5%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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Table 10. Non-normalized bioluminescent values of PS|Lu|C%. The last
bioluminescent value of emulsions containing Palm stearin (PS), Lecithin (Lu) and
carvacrol at 1, 2, and 2.5% are compared to the same emulsion lacking of carvacrol.
Emulsion

C%

Dilution
(ppm)

Final light value
(photons/s)

Standard
Deviation

PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C
PS|Lu|C

0
1
0
1
0
1
0
2
0
2
0
2
0
2.5
0
2.5
0
2.5

500
500
750
750
1000
1000
500
500
750
750
1000
1000
500
500
750
750
1000
1000

2511758
13960
1625100
9866
1759863
8014
4147972
17026
3299536
6872
2255308
3668
2767154
5998
2070672
4206
1857754
6362

838048.81
3886.26
879510.73
1043.69
1295157.99
359.21
0.00
3114.10
0.00
854.18
0.00
220.62
193812.31
229.10
68996.65
144.25
32575.00
1405.73

These results show that microbial inactivation cannot be correlated to
bioluminescence because photon emission was completely inhibited with the addition of
carvacrol-containing nanoemulsions while at certain concentrations cells remained viable.
These results suggest interference of carvacrol with the bioluminescent pathway directly
or other metabolic pathways which provide substrates and cofactors for the
bioluminescent reactions.
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3.4.2.1 Dosee-response (BA50)
Emulssions contain
ning 1% and
d 2% carvacrrol, the antim
microbial acttivity increassed
co
orresponding
gly from low
wer to higherr concentratiions (i.e. from 500 ppm to 1000 ppm
m).
However,
H
thiss effect was not noticeab
ble in emulsiions with 2.55% carvacrool whereas
reegardless of the final con
ncentration E.coli
E
O157::H7 lux was completely inactivated
ex
xcept for thee CO|Lu|C2.5% emulsion
n (table 6).
Dose response exp
periments were
w conducteed to undersstand if the 22.5% carvacrrol
em
mulsions weere equally effective
e
at lo
ower concenntrations. Alll nanoemulssions containning
2.5% of carvaacrol were diluted
d
to 250
0 and 350 pppm and the bbioluminesceence responsse of
Escherichia
E
coli
c O157:H7
7 lux was monitored
m
forr 10 min folloowed by plaating as described
prreviously. The results were
w as expeccted; lower cconcentrationn (250 ppm)) resulted in
lo
ower luminescence decreease comparred to the higgher concenttration (350 ppm) that
reesulted in a higher
h
lumin
nescence deccrease. The m
most noticeaable change iin
bioluminescence emission
n from 250 ppm
p
to 350 pppm was PS
STwC2.5% w
with
ap
pproximately
y a 10% deccrease (figuree 12). As preedicted, the lower the cooncentration the
higher the num
mber of surv
vivors as sho
own in table 11.
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Table 11. Microbial enumeration at three different dilutions of emulsions containing
2.5% carvacrol. Samples were diluted to: 250 ppm, 350 ppm and 500 ppm and plated
after 10 min of contact time with Escherichia coli O157:H7 lux. The initial bacterial
concentration was 106 CFU/mL
Dilution (ppm)
System
CO|Lu|C2.5%
CO|Tw|C2.5%
PS|Lu|C2.5%
PS|Tw|C2.5%

250
7.55E+05
9.68E+05
7.90E+05
9.63E+05

350
5.93E+05
1.05E+05
1.78E+05
3.63E+05

500
4.08E+03
0.00E+00
0.00E+00
1.37E+04
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Figure 12. Bioluminesscent respon
nse of Escheerichia coli O
O157:H7 lu
ux to emulsioons
containing
c
2.5%
2
of carv
vacrol and diluted to 2250 and 350 ppm. Bioluuminescence was
monitored
m
fo
or ten minutees in the pressence of fourr emulsions:: A) COLuC
C, B) COTwC
C, C)
PSLuC, and
a D) PSTw
wC. Biolumiinescence deecreased to bbackground llevels in botth
scenarios. However, it decreased slightly
s
moree at 350 ppm
m. Insets are zooms of eaach
graph
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BA50 value is defined as the percentage of test compound that kills 50% of the
bacteria under the test conditions. CFUs values of each dilution (250, 350, and 500 ppm)
were matched with the average control values to estimate the percentage of killed
bacteria (equation 4). Each of the dose-response profiles was analyzed graphically and
the BA50 values were estimated by linear regression (Rojas-Graü et al. 2007). The lower
the BA50 value, the higher the antimicrobial activity.

%killed bacteria= 1-(N/N0)

Equation 4

Where N is the CFU values after exposure to carvacrol-loaded nanoemulsions and N0 is
the CFU values after contact with nanoemulsions lacking carvacrol.
All emulsions resulted in similar BA50 values, and ranged from 0.0236% for
PS|Lu|C2.5% to 0.0303% for PS|Tw|C2.5%. A previous study reported carvacrol BA50
values against E.coli O157:H7 between 0.0082% and 0.0088% when tested on cloudy
apple juice at 37°C for 120 min of contact time (Friedman et al. 2004). The lower BA50
values obtained by Friedman et al. compared to the ones determined in this study might
be due to the following: this study was conducted at room temperature whereas their
study was at 37°C, also the contact time in our study was 10 min as opposed to 120 min.
Likewise, Friedman and colleagues did not encapsulate carvacrol in nanoemulsions as
antimicrobial delivery vehicles.
However, Rojas-Graü et al. (2007) studied the effect of using apple puree edible
films as carriers for 0.1% oregano oil against E.coli O157:H7. They reported BA50
values of 0.034% and 0.024% after 3 min and 30 min of contact time respectively and it
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was suggested that oregano oil may have a dual benefit by imparting antimicrobial
properties, and by enhancing the water barrier properties of the films which is key to
ensure their stability.

0.0350
0.0276

0.0300

0.0282

0.0303
0.0236

BA50 (%)

0.0250
0.0200
0.0150
0.0100
0.0050
0.0000
Emulsion
COLuC2.5%

COTwC2.5

PSLuC2.5%

PSTwC2.5%

Figure 13. Bactericidal activities (BA50) of all nanoemulsions containing 2.5% of
carvacrol. The lower the BA50 value, the more effective the emulsion is. These values
were calculated using Escherichia coli O157:H7 lux with emulsions lacking carvacrol as
control.
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3.4.3

Effect of carvacrol oon biolumineescence

3.4.3.1 Reveersibility of carvacrol efffect
The reesults show that
t biolumiinescence is dramaticallyy reduced inn the presencce of
nanoemulsion
ns loaded wiith any amou
unt of carvaccrol. However, cell inacttivation onlyy
occurs when antimicrobiaal concentrattion in the em
mulsions is bbetween 2%
% and 2.5%.
Therefore,
T
ex
xperiments to
o understand
d the mechannism of actioon of carvacrrol encapsulated
in
n nanoemulssions were co
onducted as previously ddescribed. Thhe positive ccontrol
(eemulsion witth no carvaccrol) increaseed its light em
mission everry minute w
with an average
raate of 26,144
4 RLUs min-1
before the addition of glucose. Thhe value recoorded for thiss

em
mulsion at th
he five minu
ute time poin
nt (the last m
measurement before addinng 1 mL of
glucose) was 214,946 RL
LU/s and, aftter the additiion of glucosse (1000 ppm
m) it increased
up
p to 1,085,753 RLU/s. On
O the contraary, the bioluuminescencee coming froom E. coli
O157:H7
O
lux in presence of PS|Lu|C2
2% decreaseed to backgroound levels iin less than ffive
minutes.
m
Interrestingly, on
nce the carvaacrol was rem
moved from the solutionn by
ceentrifugation
n and resusp
pension of the cells in gluucose (1000 ppm) a recoovery in lighht was
reeported from
m background
d levels to allmost 200,0000 RLU/s (F
Figure 14). T
This result allong
with
w the correesponding in
nactivation data
d suggestss the antimiccrobial actionn of carvacrool is
reeversible at lower
l
concen
ntrations. Du
uarte-Gómezz et al. (20144) used bioluuminescencee to
in
nvestigate th
he effect thatt high hydrosstatic pressuures (69, 103 and 138 MP
Pa) have on
Pseudomonas
P
s fluorescencce 5RL and Escherichia
E
coli VF luxx. Similar to the results fo
found
in
n this study, luminescencce emission decreased w
when high prressures weree applied.
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However, light recovered after the pressure was released suggesting that the action of
high pressures on bacteria was also reversible. In addition, pressure treatments above
100MPa resulted in bacterial inactivation of Pseudomonas fluorescence 5RL which is
comparable to the antimicrobial effect that higher carvacrol concentrations (emuslions
with 2.5% carvacrol) had on E. coli O157:H7 lux in the present study.
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Figure
F
14. Liight response of Escherrichia coli O
O157:H7 in presence an
nd removal of
PS|Lu|C0%
P
C2% at 500
0 ppm. The eemulsion waas removed bby centrifuggation
and PS|Lu|C
an
nd the resulttant pellet was resuspend
ded in MSM
M glucose (10000 ppm). N
Note the
difference
d
in light effect when
w
carvacrol is presennt and absennt.
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It has been shown
n that disinfeecting substaances such ass chlorine diioxide gas (C
ClO2)
ex
xhibit a lineaar relationsh
hip (R2 = 0.99
943) betweeen luminesceence (photonns/s) and celll
viability (CFU
U/filter) (dell Busto-Ram
mos et al. 20008). The ratee of light deccrease was ddosedependent wh
hen differentt concentratiions of ClO2 (0.5, 1, 1.6,, and 2.1 mg/L) were testted
ag
gainst Pseud
domonas fluo
orescences 5RL
5
(del Bu sto-Ramos eet al. 2008). Also,
Loimaranta
L
et al. (1998) found
f
that when
w
a biolum
minescent Sttreptococcuss mutans straain
was
w treated with
w chlorhex
xidine, and penicillin
p
thee bacterial loog reduction was easily
co
orrelated witth biolumineescence emisssion in a doose and time dependant m
manner. Sim
milar
reesults were found
f
by Au
uer (2009) wh
hen a lethal dose (1.2 m
mg/L) of ClO2 was testedd
ag
gainst Escheerichia coli O157:H7
O
lux
x and 97.4%
% of bioluminnescence waas lost in justt ten
seeconds contaact time with
h approximaately 7-log reeduction in bbacterial cellls. However,, the
bioluminescent response of E. coli O157:H7 to fiive sub-lethaal doses of 0.1 mg/L of C
ClO2
was
w not cumu
ulative in com
mparison to one single aaddition of 00.5 mg/L of C
ClO2. Thus, it
was
w hypothessized that thee mechanism
m of inactivat
ation of ClO2 was not by oxidation of
prroteins but by
b interfering
g with energ
gy moleculess such as NA
ADH and NA
ADPH. Therrefore,
siince in this work
w
biolum
minescence deecreased in ppresence of emulsions looaded with
caarvacrol eveen though cellls remain viiable, it was hypothesizeed that carvaacrol mode oof
acction is due oxidative ph
hosphorylatio
on uncouplinng.

3.4.3.2 2,4-D
Dinitropheno
ol and carvaacrol comparrisons
To tesst this hypoth
hesis, 2.4-Diinitrophenoll (2,4-DNP),, a well-know
wn oxidativee
ph
hosphorylatiion uncoupleer was tested
d against Esccherichia cooli O157:H7 lux. The
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experiment was conducted in situ using a photo multiplier tube (PMT) (Hamamatsu,
AC135, Iwata-gun, Japan) sensor module in a light-tight box integrated with a
programmable logic controller interfaced with a PC for data acquisition as previously
described. Sub-lethal doses of 2,4 DNP were added to the bioluminescent strain and
bioluminescence was monitored for 600 seconds. The relative bioluminescence of E. coli
O157:H7 lux decreased immediately by 80%, 50%, or increased 20% after addition of
1mM, 0.5mM, and 0.1mM doses of 2,4-DNP respectively. Cells were tested for viability
after ten min of contact time with this compound. However, no cell inactivation was
observed (Figure 15). This chemical is known to uncouple oxidative phosphorylation
(Gage and Neidhardt 1993, Haidinger et al. 2003, Miranda et al. 2006), thus blocking
ATP production. The bioluminescent reaction requires ATP and NADPH as cofactors for
the reduction of myristic acid to myristyl aldehyde which in presence of FMNH2, O2 and
the luciferase emits light at a wavelength of 490 nm (Figure 3). Therefore, the decrease in
light emission occurs with decreasing ATP production. As a result, the similarity on the
bioluminescent behavior and the incapacity to reduce bacterial population at sub-lethal
doses of carvacrol or 2,4-DNP, is a key observation to hypothesize that carvacrol acts in a
similar manner as 2,4-DNP by uncoupling oxidative phosphorylation.
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A

B
Solvent
2,4‐DNP
2,4‐DNP
2,4‐DNP

Concentrattion
(ppm)
19
92
184

Bacterial
B
Log
initial (CFU/mL))
6.23±0.07
6.23±0.07
6.23±0.07

Bacteriaal Log reductio
on (CFU/mL)
0.04±0.01
1
0.03±0.02
2
0.05±0.06
6

Figure
F
15. Addition of sub-lethal do
oses of 2,4-D
DNP (0.1 mM, 0.5 mM,, and 1mM)) to
Escherichia
E
coli
c O157:H
H7 lux. A) Th
he relative bbioluminesceence of E. cooli O157:H77 lux
decreased by 80%, 50%, and increaseed 20% whenn treated witth 1mM, 0.55mM, and
0.1mM dosess of 2,4-DNP
P respectivelly. B) Howevver, the addiition of this compound ddid
not result in a decrease in
n the concenttration of viaable cells.
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3.4.3.3 Add
dition of n-deecanal
Accorrding to the bioluminesc
b
ent pathwayy, when ATP
P is lacking nno myristyl
alldehyde is prroduced and
d therefore no
o light is em
mitted. Howeever, the adddition of a lonng
ch
hain aldehyd
de, such as n-decanal,
n
sh
hould result iin photon em
mission at 4990 nm in the
prresence of FMNH
F
ferase whichh opens the ddoor to severral food safeety
2, O2, and the lucif
ap
pplications. The additio
on of n-decan
nal (in excesss) eliminatees the need fo
for the syntheesis
of the aldehyd
de substrate thus requirin
ng only the iinsertion of the luxAB innto the bacteerial
sttrain of interrest. This ap
pproach also eliminates ssubstrate lim
mitation for thhe luciferasee
reeaction. Forr example, th
he imaging of
o biolumineescent coloniies of Escherrichia coli
O157:H7
O
and
d Listeria mo
onocytogeness in Camembbert and Fetta cheeses was possible ddue
to
o the addition
n of 10µl off 1% n-decan
nal in the nonn-selective m
medium to hhighlight the
bioluminescent colonies out
o of the cro
owed plates containing tthe starter cuulture and thhe
native flora of raw milk (Ramsaran ett al. 1998). A
Another casee is the consttruction of a
lu
uciferase-tran
nsducing ɸV
V10 bacteriophage whichh is dependeent to n-decaanal for
bioluminescence emission
n and is usefful for the deetection of E
E. coli O157:H7 (Waddeell
an
nd Poppe 20
000).
To un
nderstand if myristyl
m
aldeehyde was nnot being gennerated due tto the lack of
ATP,
A
n-decan
nal (Sigma Aldrich,
A
St Louis,
L
MO) w
was added too the biolumiinescent straain in
prresence of th
he carvacrol--containing nanoemulsio
n
on and light emission waas monitoredd in
viivo for 10 minutes.
m
Each
h nanoemulsion was addded after one minute of liight monitorring
an
nd it was folllowed by th
hree addition
ns of n-decannal at minutees 2, 4.5, andd 7.
Bioluminesce
B
ence recoverry of 25%, 14
4%, and 10%
% was obserrved respectiively after eaach
ad
ddition (Figu
ure 16). Thee gradually decrease
d
on bbioluminesceent recoveryy can be
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explained by the lack of glucose in the solution resulting in no synthesis of FMNH2
which is a co-factor for light production. These results suggest that carvacrol was indeed
acting by uncoupling oxidative phosphorylation resulting in lack of ATP for the synthesis
of myristyl aldehyde in the bioluminescent cycle. The addition of n-decanal (substitute of
myristyl aldehyde) provided a substrate which in the presence of oxygen and FMNH2
emitted a photon by the action of luciferase, encoded by the luxAB genes.

D

B
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Figure
F
16. Addition of n-decanal
n
to
o Escherichiia coli O1577:H7 lux in p
presence of
ca
arvacrol-containing na
anoemulsion
ns. Escherichhia coli O1557:H7 lux beehavior in
prresence of: A)
A Palm Steaarin|Lecithin
n|Carvacrol 22% (750 ppm
m) and n- deecanal. B) Paalm
Stearin| Tweeen 20| Carvaacrol 2% (750 ppm) and n-decanal. C
C) Palm
hin|Carvacro
ol 2% (750 ppm),
p
and D)) Palm Stearrin| Tween 20| Carvacroll 2%
Stearin|Lecith
(7
750 ppm). An
A increase in
n light after each additioon of n-decannal is observved.
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3.4.4

ATP Swab Hygiene Test

Adenosine triphosphate (ATP) is one of the cofactors in the bioluminescent
reaction cycle, and each cell contains a constant intracellular ATP pool that is effectively
regulated. Therefore, in situ light emission is a sensitive and rapid indicator of the
intracellular state of cells (Stanley 1989), and is an effective way to estimate microbial
activity and the quantity of microorganisms present (Lin et al. 2013). At least 104 cells
are required to produce a signal (de Boer and Beumer 1999). In this study, the
bioluminescence-based ATP hygiene monitoring system was used to measure the
remaining ATP after ten min of contact time between cells and nanoemulsions loaded
with carvacrol.
A standard curve was developed using an ATP standard with an original
concentration of 10mM. The range of the reaction was between 691,480.5 RLU/s and
189.5 RLU/s which corresponded to 100 nM and 0.01 nM of ATP respectively. The
resulting linear regression was:
y=0.0001x-1.5833

Equation 5

Where ‘y’ is the ATP concentration (nM) and ‘x’ is light (RLU/s) (Figure 17). The
amount of ATP detected when carvacrol-loaded nanoemulsions were tested against E.
coli O157:H7 was 335-fold less than those without carvacrol (T-test<0.05). ATP values
were between 0.2 nM and 0.8nM. However, the controls (emulsions with no carvacrol)
had ATP concentrations up to 67 nM (figure 18). Helander et al. (1998) demonstrated
that at 300 ppm of carvacrol, the ATP pool changed from 3.1 to 0.3nM/mg. ATP has
been shown to be a sensitive indicator molecule for the presence of biologically active
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orrganisms and is a rapid tool
t
for the analysis
a
of eeffectivenesss of antimicrrobials even if
th
hey have diff
fferent mechaanisms of acction (Loimaaranta et al. 11998). In facct, a NASA
patent on 197
77 was develloped with th
he objective of using thee luciferase aassay to meaasure
th
he antimicrobial drug susceptibility of
o different aantibiotics, ssuch as: amppicillin,
caarbenicillin, cephalothin
n, penicillin G,
G and clinddamycin (Chaappelle et all. 1977).

Figure
F
17. ATP Standarrd Curve. Original
O
ATP
P Standard (110mM, (Biollabs, P0756S
S,
Ip
pswich, MA, United Stattes) was dilu
uted to createe a standard curve. Bioluuminescencee was
measured
m
usin
ng a Zylux (Femtomaste
(
er FB14, D-775173, Pforzzheim, Germ
many) after
ad
ddition of ATP
A swab reaagent. Resultts were analyyzed againstt the resultinng standard ccurve
with
w a R2=0.9
9966
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Figure
F
18. ATP values of
o Escherich
hia coli O1577:H7 in preesence and aabsence of
ca
arvacrol-loa
aded emulsiions. The eff
ffect on ATP
P levels (nM)) of emulsionns containinng
different conccentrations of
o carvacrol (lighter barss) and emulsions with noo carvacrol
(d
darker bars) have on Esccherichia colli O157:H7 llux after tenn min of conttact time was
ev
valuated. A)) Palm Steariin, Lecithin, and 1% of ccarvacrol. B
B) Palm Stearrin, Lecithinn, and
2% carvacrol. C) Palm Sttearin, Lecith
hin, and 2.5%
% carvacrol. T-test <0.005. The rest oof
th
he treatments can be foun
nd in the ann
nex section.
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Previous studies have reported that the mechanism of action of carvacrol might be
due to the accumulation of the antimicrobial in the cytoplasmic membrane causing
expansion, and having repercussions in both the lipid ordering and the bilayer stability
hence damaging membrane integrity and increasing the proton passive flux across the
membrane (Ultee et al. 1999, Cox et al. 2000, Ultee et al. 2002). Earlier studies suggested
that the mode of action of carvacrol might be due to the impairment of various enzyme
systems, such as those involved in the production of cellular energy and synthesis of
structural components (Conner and Beuchat 1984). However, this work suggests that
carvacrol acts as an oxidative phosphorylation uncoupler blocking the electron transport
chain and therefore, ATP production. This hypothesis can be supported by Ultee et al.
(2002). They conducted several experiments using carvacrol against Bacillus cereus and
concluded that although carvacrol caused destabilization on the membrane and a decrease
on the membrane potential, it is more probable that the antimicrobial activity of carvacrol
might be due to the decrease in the ΔpH as a result of its hydroxyl group and a system of
delocalized electrons. With this being said, the action of carvacrol will result in the
absence of a proton motive force, and as consequence, a disablement on ATP synthesis
which leads to a weakening of vital processes in the cell and finally to cell death.
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CHAPTER 4. CONCLUSIONS AND FUTURE WORK

In this research, the antimicrobial effect of nanoemulsions containing carvacrol was
investigated and a mechanism of action of this antimicrobial was proposed. The
bioluminescent response of Escherichia coli O157:H7 lux was monitored in presence of
each of the different nanoemulsions and the resulting sample was plated for cell viability
after ten minutes of contact time. Contrary to expected, a discrepancy between
bioluminescence and cell viability was found whereas the first one decreased abruptly in
presence of carvacrol regardless of the antimicrobial concentration, and unexpectedly,
bacterial cells survived when the emulsions applied had 1% (with concentrations of
500,750, and 1000 ppm) or 2% carvacrol (with concentrations of 500 ppm). The same
bioluminescent response was found when Escherichia coli O157:H7 lux was monitored
in presence of 2,4-Dinitrophenol, a well-known oxidative phosphorylation uncoupler.
The comparison of both scenarios lead to the hypothesis of the similarity of modes of
action. This finding was confirmed when bioluminescence was monitored in presence of
both carvacrol containing nanoemulsions and n-decanal. Spikes of light were observed
immediately after addition of n-decanal regardless of the presence of carvacrol. ATP
concentrations were then investigated in presence and absence of the antimicrobial. In
agreement with the previous results, the presence of carvacrol, which is proposed to act
by uncoupling oxidative phosphorylation, caused a decrease in ATP.
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This study contributes to the knowledge of carvacrol and its antimicrobial
mechanism of action and opens opportunities for further directions. More studies are
required to determine the effects of environmental factors such as pH, temperature, and
media nutrients, in the carvacrol antimicrobial efficacy. There is a need to understand the
effect of carvacrol on not only Gram positives, and other foodborne pathogens, but on
eukaryotes such as yeast and amoeba as well. The results of this work could be compared
to other antimicrobials found in essential oils, such as eugenol, p-cymene, menthol,
geraniol, limonene, and specially thymol which is an isomer of carvacrol. Furthermore, it
is important to complement the results of this study with the evaluation of the membrane
potential and proton motive force in the presence of carvacrol and the bioluminescence
response from other bacterial strains expressing the luxCDABE genes used in this study.
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App
pendix A

Nanoemulssions effect oon bacterial luminescencce productioon

Coconut oil (CO), Lecithhin (Lu) andd 1%
Figure
F
19. Effect
E
of nanoemulsions containing C
m.
of carvacrrol at differeent dilutions:: 500, 750 annd 1000 ppm
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Figure 20. Efffect of nanoemulsions containing Cooconut oil (C
CO), Lecithiin (Lu) and 22%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.

86

Figure 21. Efffect of nanoemulsions containing Cooconut oil (C
CO), Lecithiin (Lu) and 22.5%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.

87

oemulsions containing
c
P
Palm Stearinn (PS), Tweeen 20 (Tw) aand 1%
Figure 22. Efffect of nano
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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oemulsions containing
c
P
Palm Stearinn (PS), Tweeen 20 (Tw) aand 2%
Figure 23. Efffect of nano
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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Figure 24. Efffect of nanoemulsions containing Paalm Stearin ((PS), Tweenn 20 (Tw) annd 2.5%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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CO), Tween 20 (Tw) andd 1%
Figure 25. Efffect of nanoemulsions containing Cooconut oil (C
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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CO), Tween 20 (Tw) andd 2%
Figure 26. Efffect of nanoemulsions containing Cooconut oil (C
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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Figure 27. Efffect of nano
oemulsions containing
c
C
Coconut oil (C
CO), Tweenn 20 (Tw) annd 2.5%
of carvacrol at
a different dilutions:
d
500
0, 750 and 1 000 ppm.
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Appendix B

Non-normalized bioluminescent results

Bioluminescence was monitored every second for ten minutes. Tables SS shows
the non-normalized results for the 600th second. A noteworthy difference is observed
between the bioluminescence emitted by E. coli O157:H7 lux in presence and absence of
carvacrol.
Table 12. Non-normalized bioluminescent values of CO|Lu|C%. The last
bioluminescent value of emulsions containing Coconut oil (CO), Lecithin (Lu) and
carvacrol at 1, 2, and 2.5% are compared to the same emulsion lacking of carvacrol.
Emulsion

C%

Dilution (ppm)

Final light value
(photons/s)

Standard
Deviation

CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C
CO|Lu|C

0
1
0
1
0
1
0
2
0
2
0
2
0
2.5
0
2.5
0
2.5

500
500
750
750
1000
1000
500
500
750
750
1000
1000
500
500
750
750
1000
1000

108138
12020
986694
17782
563098
10304
710476
32076
765596
6968
4680898
8520
1269550
8426
1101834
5248
978752
3696

992.78
22.63
200651.45
6151.83
119882.88
989.95
0.00
29059.26
0.00
1708.37
38197.91
4830.95
76138.43
726.91
49822.74
1538.66
12942.88
452.55
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Table 13. Non-normalized bioluminescent values of CO|Tw|C%. The last
bioluminescent value of emulsions containing Coconut oil (CO), Tween 20 (Tw) and
carvacrol at 1, 2, and 2.5% are compared to the same emulsion lacking of carvacrol.
Emulsion

C%

CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C
CO|Tw|C

0
1
0
1
0
1
0
2
0
2
0
2
0
2.5
0
2.5
0
2.5

Dilution
(ppm)
500
500
750
750
1000
1000
500
500
750
750
1000
1000
500
500
750
750
1000
1000

Final light value
(photons/s)
256064
23374
225720
12332
315610
6684
5201999
686666
686666
902570
1090175
11080
6469138
19318
4400588
7258
3773414
4344

Standard
deviation
109149.00
6287.59
109397.90
2522.96
3606.24
4038.99
121055.27
892365.93
892365.93
1236104.68
3667.06
2059.09
1278830.90
9246.13
349050.53
2231.63
221853.34
610.94
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Table 14. Non-normalized bioluminescent values of PS|Tw|C%. The last
bioluminescent value of emulsions containing Palm Stearin (PS), Tween 20 (Tw) and
carvacrol at 1, 2, and 2.5% are compared to the same emulsion lacking of carvacrol.
Emulsion

C%

PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C
PS|Tw|C

0
1
0
1
0
1
0
2
0
2
0
2
0
2.5
0
2.5
0
2.5

Dilution (ppm)
500
500
750
750
1000
1000
500
500
750
750
1000
1000
500
500
750
750
1000
1000

Final light value
(photons/s)
1952082
46610
1769052
23282
1858904
16926
1927568
7984
1529052
7344
1126988
6260
1645170
120974
1416366
5240
1341966
2304

Standard
Deviation
927036.79
10343.56
1196503.87
3238.55
1064122.17
3187.64
0.00
1736.65
0.00
379.01
0.00
588.31
128322.91
150181.00
85964.39
248.90
99687.91
2098.69
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Appendix
A
C

Biolumin
nescence ressponse to sloow addition oof emulsion

Figure
F
28. Sllow addition
n of nanoem
mulsion to E
Escherichia ccoli O157:H
H7 lux. One drop
of nanoemulssion (CO|Lu||C2%) was added
a
to E. ccoli O157:H7 lux every 30 seconds. The
to
otal nanoemu
ulsion volum
me added waas 1 mL. Biooluminescencce was moniitored in vivoo for
teen minutes. The
T red arrows representt the slow adddition of thhe emulsion
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xD

ATP Swab Hygieene test

Figure
F
29. ATP values of
o Escherich
hia coli O157:H7 in preesence and aabsence of
ca
arvacrol-loa
aded emulsiions. The eff
ffect on ATP
P levels (nM)) that emulsiions containiing
different conccentrations of
o carvacrol (lighter barss) and emulsions with noo carvacrol
darker bars) have on Esccherichia colli O157:H7 llux after tenn min of conttact time was
(d
ev
valuated. Th
he presence of
o carvacrol reduces connsiderably thhe ATP amouunt in
co
omparison with
w the conttrol. A) Palm
m Stearin, Tw
ween 20, andd 1% of carvvacrol. B) Paalm
Stearin, Tweeen 20, and 2%
% carvacrol. C) Palm Sttearin, Tweeen, and 2.5%
% carvacrol
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Figure
F
30. ATP values of
o Escherich
hia coli O157:H7 in preesence and aabsence of
ca
arvacrol-loa
aded emulsiions. The eff
ffect on ATP
P levels (nM)) that emulsiions containiing
different conccentrations of
o carvacrol (lighter barss) and emulsions with noo carvacrol
(d
darker bars) have on Esccherichia colli O157:H7 llux after tenn min of conttact time was
ev
valuated. Th
he presence of
o carvacrol reduces connsiderably thhe ATP amouunt in
co
omparison with
w the conttrol. A) Coco
onut oil, Leccithin, and 1%
% of carvacrrol. B) Cocoonut
oil, Lecithin, and 2% carv
vacrol. C) Coconut oil, L
Lecithin, andd 2.5% carvaacrol
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Appendix E

Minimal Inhibitory Concentration

The minimal Inhibitory Concentration (MIC) of nanoemulsions against Escherichia
coli O157:H7 was determined by comparing two methods: Well Diffusion Agar Mueller
Hinton Agar (WDA) and Disk Diffusion Agar (DDA).

Well Diffusion Agar
The method of Puupponen‐Pimiä et al. (2001) was slightly modified. A sterile
cotton swab was immersed into 10mL Escherichia coli O157:H7 lux. The excess was
removed and LB Kan plates were inoculated by spreading. The plate was kept at room
temperature for about 10 minutes until dry. A 4 mm well was opened using a sterile cork
borer. Emulsions were diluted in sterile and distilled water to the desired carvacrol
concentrations based on the carvacrol content (500, 750, and 1000 ppm). 50 µL of
emulsion diluted to the desired concentration was added to each well.
Plates were stored at 4°C overnight and then were moved to an incubator at 37°C
overnight 912-18hr). The diameter of inactivation zone was recorded using an Electronic
Digital Caliper VWR.

Disk Diffusion Agar
Bacteria were spread in LB Kan plates as explained in the Well Diffusion Agar
method. 50 µL of the emulsion at different concentration (500, 750, 1000 ppm) were
applied to sterile filter paper disks (7 mm). Disks were placed at the top of the plate and
the same incubation process used for WDA was conducted (Klančnik et al. 2010)
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Table 15. MIC values emulsions diluted to 500 ppm. Two different methods were used:
Well Diffusion Agar (WDA) and Disk Diffusion Agar (DDA)
500 ppm
Nanoemulsion
CO|Lu|C1%
CO|Lu|C2%
CO|Lu|C2.5%
CO|Tw|C1%
CO|Tw|C2%
CO|Tw|C2.5%
PS|Lu|C1%
PS|Lu|C2%
PS|Lu|C2.5%
PS|Tw|C1%
PS|Tw|C2%
PS|Tw|C2.5%

WDA
1.41±0.76
2.00±0.17
3.93±0.50
0.00±0.33
2.98±1.65
2.54±0.28
1.44±0.01
2.03±0.10
9.96±1.75
2.92±0.16
6.01±2.67
12.50±5.78

DDA
0.39±0.00
1.61±0.46
3.09±0.65
2.48±0.25
2.96±0.89
3.68±0.69
0.00±0.00
0.85±0.33
3.14±1.24
0.34±0.47
2.89±1.73
4.48±0.94

Table 16. MIC values emulsions diluted to 750 ppm. Two different methods were used:
Well Diffusion Agar (WDA) and Disk Diffusion Agar (DDA)
750 ppm
Nanoemulsion
CO|Lu|C1%
CO|Lu|C2%
CO|Lu|C2.5%
CO|Tw|C1%
CO|Tw|C2%
CO|Tw|C2.5%
PS|Lu|C1%
PS|Lu|C2%
PS|Lu|C2.5%
PS|Tw|C1%
PS|Tw|C2%
PS|Tw|C2.5%

WDA
1.91±0.11
5.32±2.09
5.51±0.55
1.18±0.21
4.74±0.01
3.61±1.08
3.53±0.32
3.96±1.16
5.49±0.22
5.20±0.82
7.76±2.46
13.37±5.93

DDA
0.95±0.11
1.98±0.04
4.15±0.16
2.63±0.00
3.98±0.02
3.35±0.39
0.67±0.29
1.19±0.45
1.60±0.45
1.47±0.42
3.40±2.02
4.92±1.36
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Table
T
17. MIIC values em
mulsions dilluted to 10000 ppm. Twoo different m
methods were
used: Well Diffusion Agaar (WDA) an
nd Disk Difffusion Agar (DDA)
1000
1
ppm
Nanoemulsio
N
on
CO|Lu|C1%
C
CO|Lu|C2%
C
CO|Lu|C2.5%
C
%
CO|Tw|C1%
C
CO|Tw|C2%
C
CO|Tw|C2.5%
C
%
PS|Lu|C1%
PS|Lu|C2%
PS|Lu|C2.5%
%
PS|Tw|C1%
PS|Tw|C2%
PS|Tw|C2.5%
%

A

WDA
2.56±0.711
8.29±1.533
9.14±1.977
1.81±0.166
6.52±0.499
6.77±1.800
4.06±0.100
5.49±0.222
11.49±0.994
6.63±0.511
8.88±2.244
13.93±6.223

DDA
1.07±0
0.28
3.01±0
0.17
4.48±0
0.28
3.29±0
0.78
4.30±0
0.41
4.27±0
0.93
1.17±0
0.42
1.60±0
0.45
4.76±1
1.11
1.22±0
0.18
3.95±0
0.66
5.70±1
1.27

B

Figure
F
31. Zo
ones of bactterial inhibiition of carvvacrol-loadeed nanoemu
ulsions on E
E.
co
oli O157:H7
7. A) Well Difussion
D
Ag
gar (WDA). B
B) Disk Diff
ffusion Agar (DDA). Thee
higher the inh
hibition zonee, the higher the antimicrrobial activiity.
.
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Appendix F

Statistical output

Table 18. One-way ANOVA (p<0.05). Independent variables: Emulsifier, Oil,
Carvacrol Dilution and interactions. Dependent variable: Bacterial Enumeration.
Source

DF

Model

19

1.4729828E14

7.7525408E12

Error

52

8.9768951E13

1.726326E12

Corrected Total

71

2.3706723E14

R-Square
0.621335

Sum of Squares

Coeff Var
161.1430

Source

Root MSE
1313897

DF

Mean Square

Type I SS

F Value

Pr > F

4.49

<.0001

Bacterial Mean
815361.1

Mean Square

F Value

Pr > F

Emulsifier

1

2.4125624E12

2.4125624E12

1.40

0.2425

Oil

1

2.0818541E12

2.0818541E12

1.21

0.2772

Carvacrol

2

2.6766922E13

1.3383461E13

7.75

0.0011

Dilution

2

2.9918883E13

1.4959441E13

8.67

0.0006

Emulsifier*Oil

1

4.7448428E12

4.7448428E12

2.75

0.1034

Emulsifier*Carvacrol

2

3.0226784E13

1.5113392E13

8.75

0.0005

Emulsifier*Dilution

2

573971103611

286985551806

0.17

0.8473

Oil*Carvacrol

2

2.0497385E13

1.0248693E13

5.94

0.0048

Oil*Dilution

2

7.5593397E12

3.7796698E12

2.19

0.1222

Carvacrol*Dilution

4

2.2515731E13

5.6289327E12

3.26

0.0185
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Table 18 continued
Source

DF

Type III SS

Mean Square

F Value

Pr > F

Emulsifier

1

2.4125624E12

2.4125624E12

1.40

0.2425

Oil

1

2.0818541E12

2.0818541E12

1.21

0.2772

Carvacrol

2

2.6766922E13

1.3383461E13

7.75

0.0011

Dilution

2

2.9918883E13

1.4959441E13

8.67

0.0006

Emulsifier*Oil

1

4.7448428E12

4.7448428E12

2.75

0.1034

Emulsifier*Carvacrol

2

3.0226784E13

1.5113392E13

8.75

0.0005

Emulsifier*Dilution

2

573971103611

286985551806

0.17

0.8473

Oil*Carvacrol

2

2.0497385E13

1.0248693E13

5.94

0.0048

Oil*Dilution

2

7.5593397E12

3.7796698E12

2.19

0.1222

Carvacrol*Dilution

4

2.2515731E13

5.6289327E12

3.26

0.0185

